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The important thing is not to stop questioning. Curiosity has its own reason for existing. 
—Albert Einstein 
 
  
iv 
ACKNOWLEDGMENTS 
 
 I would like to thank all of the people who made this dissertation possible, start-
ing with my Mentor Dr. Alan Wolfe. Alan was a great mentor and a perfect match for 
these years of graduate school. He knew exactly, or almost, how to gently but consistent-
ly challenge and push me to always dig a little bit deeper and do the best that I could. His 
guidance helped me realize that I could always push my limits a little bit further. I also 
want to thank my Graduate Program Director and committee chair Dr. Karen Visick for 
the immense support I received during my years of graduate school. Karen played an in-
strumental role in helping me develop the ability to critically analyze my data. Finally, I 
would like to thank the other member of my committee: Dr. Adam Driks, Dr. Thomas 
Gallagher and Dr. Linda Kenny for always being there whenever I needed help or advice 
at any point during my years of graduate school. 
 I would also like to thank Loyola University Chicago and the NIH for providing 
the funds for my research and an Arthur J. Schmidt Dissertation Fellowship for the 2011-
2012 academic year. 
My friends in the Microbiology and Immunology Department and outside of it 
have provided me with much needed cheering sections throughout the years and with 
necessary periodic breaks, allowing me to make this process as enjoyable as possible. 
Finally, I would like to thank my family that has endured my distance from my home 
country for all these years that I have spent in the United States pursuing my Ph.D.
  
v 
  TABLE OF CONTENTS  
 
ACKNOWLEDGMENTS iv  
LIST OF TABLES viii  
LIST OF FIGURES  ix  
ABSTRACT xi  
 
CHAPTER ONE: Introduction  1  
   Two-Component Pathways 5    
   The CpxAR Two-Component Pathway  7  
   Pta-AckA Pathway and Acetylphosphate 11 
   Acetyl-Coenzyme A 14     
   Acetylation 16 
   RNA Polymerase and Transcription Initiation  22  
 
CHAPTER TWO: Materials and Methods  
   Bacterial Strains, Bacteriophage and Plasmids 26  
   Culture Conditions  26  
   Generalized P1 Transduction 27 
   Plasmid Construction 28 
   Site Directed Mutagenesis 30 
   Transformation 30 
   Promoter Activity Assay 32 
   pH Sensitivity Assay 32 
   Nile Red 33 
   Transmission Electron Micrograph 33 
   Western Immunoblot Analysis 34 
   Immunoprecipitation 35 
   Orbitrap-Mass Spectrometry and Proteins Identification            36 
   CpxR Expression and Purification 37 
   In vitro Phosphorylaion 38 
   Detection of Phosphorylated CpxR 39 
   In Vitro Acetylation 39 
   In vitro Transcription 40 
   RNA Polymerase Expression and Purification 42  
  
vi 
 
CHAPTER THREE: Results – Acetyl Phosphate as a Phosphoryl Donor   
   Does cpxP Transcription Respond to Genetic Manipulations Predicted to Affect   
      Intracellular Levels of AcP?  45  
   Stationary Phase Behavior is a CpxA-Dependent Response to Alkaline pH 49 
   cpxP Response to Excess Carbon Requires the Pta-AckA Pathway 50 
   CpxA-independent cpxP Transcription Requires the Pta-AckA Pathway but  
        Does Not Correlate with Predicted Intracellular AcP Levels. 54  
   Glucose-induced cpxP Transcription Requires AsP-51, the Conserved  
       Phosphoryl Acceptor Residue of CpxR              60 
   The Response to Glucose Requires Acetyl Phosphate            63 
   In vivo Phospho-CpxR levels Correlate with AcP but not with cpxP           63 
   Conclusions                                                                                                                    66  
 
CHAPTER FOUR: Results 
    Acetylation and Transcriptional regulation  68  
    Catabolite Repression 69 
    Glucose and AcP Affect Global Protein Acetylation            72 
    Lys-291 on RNAP αCTD Contributes to Transcription Inhibition                       78 
    Is an Acetyltransferase Required for the Weak Response to Glucose?          80 
    K291Q also Affects cpxP Transcription In vitro               82  
    Conclusions 90 
 
CHAPTER FIVE: Results    
   Acetylphosphate as an Acetyl Donor  93  
   cpxP Transcription Responds to Alterations in the Acetylome 94 
   Glucose-Induced cpxP Transcription Requires a Lysine Acetyltransferase 96 
   YfiQ is Required for in vivo acetylation of Multiple Lysines on RNAP 98 
   Glucose-Induced Transcription Requires Lys-298 of the αCTD         102 
   YfiQ does not Acetylate RNAP in vitro 103     
   AcP as an Acetyl Donor 104 
   Conclusions 105 
 
CHAPTER SIX: Discussion    
   Overall Summary   109  
   Signal Integration 110 
   The Loss of the Pta-AckA Pathway 113 
   AcP-Dependent Phosphorylation 114 
   Protein Acetylation is an Important Contributor to cpxP Transcription        116 
   AcP-Dependent Acetylation 121     
   A Role for Acetylated Lys-298 124 
   A Role for Acetylated Lys-291 127 
   Model 129 
   Concluding Remarks 130 
 
  
vii 
BIBLIOGRAPHY  141  
 
VITA  155  
  
viii 
LIST OF TABLES 
 
Table 1. Strains and Plasmids 132 
 
Table 2. The number of acetylated β and β’ peptides detected from ackA mutant cells 136         
Table 3. Acetylated α Peptides from ackA Mutant Cells 138         
Table 4. Lysine Acetylated β an β’ Peptide from WT Cells exposed to Glucose 139 
 
  
ix 
LIST OF FIGURES 
 
Figure 1. Schematic Overview of 2CST 3 
 
Figure 2. The Two-Component CpxAR 9         
Figure 3. The Pta-AckA Pathway 12         
Figure 4. AcetylCoA 15 
Figure 5. Lysine Acetylation 17 
Figure 6. Disruption of the Pta-AckA Pathway Diminishes cpxP signaling 48  
Figure 7. cpxP Response to Alkaline pH Requires CpxA 51 
Figure 8. cpxP Response to Pyruvate does not Require CpxA 52 
Figure 9. Response to Pyruvate Requires the Pta-AckA Pathway 55 
Figure 10. cpxP Response to Glucose Requires the Pta-AckA Pathway 57 
Figure 11. Excessive Glucose Inhibits cpxP Transcription 59 
Figure 12. Response to Glucose requires D51 and AcP 61 
Figure 13. Detection of Phosphorylated CpxR 62 
Figure 14. Diverse Carbon Sources Induce cpxP Transcription 70 
Figure 15. E. coli acetylome is Sensitive to Conditions that Affect cpxP transcription 71 
Figure 16. AcP Contributes to Global Protein Acetylation 75 
Figure 17. Acetylated Lys-291 Mass Spectrum 76 
Figure 18. Lys-291 Inhibits cpxP Transcription 81 
Figure 19. Screen of Acetyltransferases 83 
Figure 20. CpxR is Required for in vitro cpxP Transcription 86 
Figure 21. AcP is Required for in vitro cpxP Transcription 87 
Figure 22. AsP-51 of CpxR is Required for in vitro cpxP Transcription 88 
  
x 
Figure 23. Lys-291 of αCTD is Required for in vitro cpxP Transcription 89 
Figure 24. Nicotinamide Induces cpxP transcription and CobB Inhibits it 95 
Figure 25. Glucose Response Requires YfiQ 97 
Figure 26. Acetylated Lys-297 and Lys-298 Spectra 100 
Figure 27. Glucose-Induced cpxP Transcription Requires Lys-298 101 
Figure 28. In vitro Acetylation with AcP 107 
xi 
 
ABSTRACT 
 
The ability of bacteria to sense and adapt to environmental changes has al-
lowed these organisms to thrive in all parts of the globe and to establish many com-
plex interactions with the environments in which they live as well as with other 
members of these environments. Crucial to monitoring extracellular conditions is a 
group of signaling pathways known as two-component signal transduction systems 
(2CST). These systems relay information from the extracellular environment to the 
interior of the cell via a transfer of phosphoryl groups from the sensory protein 
known as a sensor kinase (SK) to the output protein known as a response regulator 
(RR).  
In addition to this constant input of extracellular information, bacterial cells 
also monitor their intracellular environment, as among other things, it provides pre-
cious information about their nutritional status. It is the integration of these extra-
cellular and intracellular cues that will determine which genes should be tran-
scribed, assuring the most appropriate response for each environment at any given 
time.  
Here, I present evidence that one of these 2CST systems in E. coli, the CpxAR 
system, integrates signals originated from both the extracellular environment and 
from central metabolic pathways to modulate transcription of the CpxR-dependent 
  
xii 
 
gene cpxP.  Through a series of genetic and biochemical experiments I demonstrate 
that acetyl-phosphate (AcP), a central metabolite originated from the Pta-AckA 
pathway, donates its phosphoryl group to the RR CpxR both in vitro and in vivo and 
that this transfer of phosphoryl group activates cpxP transcription. 
In addition to CpxR phosphorylation, my data suggest that cpxP transcription 
is also sensitive to an additional posttranslational modification, Nε-lysine acetylation 
of RNA polymerase (RNAP).  My data implicate the acetylation of two lysine side 
chains on the carboxyl terminal domain of the α subunit (αCTD) of RNAP in the 
modulation of cpxP transcription in response to the AcP-dependent phosphorylation 
of CpxR.  Together, CpxR phosphorylation and the acetylation of Lys-298 on αCTD 
contribute to transcriptional activation of cpxP, whereas acetylation of Lys-291 
dampens this response. Thus, protein phosphorylation and protein acetylation, 
seem to act together to fine-tune cpxP transcription. 
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CHAPTER ONE 
INTRODUCTION 
 Bacteria are ubiquitous organisms. Their wide spread prevalence plays an 
important role in the diverse environments they inhabit. In the soil, bacteria are key 
contributors to the nitrogen cycle, and different steps of this cycle are carried out by 
different groups of bacteria [reviewed in (15)].  In the ocean, bioluminescent bacte-
ria are thought to help the Hawaiian bobtail squid escape predation by providing 
light that the squid uses to counter illuminate its shadow [reviewed in (62)]. In 
mammals, gut bacteria have been shown to contribute to host metabolism, poten-
tially contributing to obesity and diabetes (13, 134). The complex and diverse mi-
crobiota in the human gut has been shown to interact with several branches of the 
immune system, influencing gut barrier and defense mechanisms. It is thought that 
these interactions influence immune homeostasis and that an imbalance in this ho-
meostasis could contribute to autoimmune diseases (22, 65).  Additionally, the hu-
man intestinal microbiota is thought to play an important role in preventing the es-
tablishment of opportunistic infection by preventing the establishment of invading 
species and/or by helping control the number of some potentially harmful members 
of the community (3).
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These different interactions with their environment are the result of many 
years of coevolution (105), resulting in an intricate and sophisticated interaction 
among the different species involved. These interactions often require that different 
organisms can sense each other and their environment, and that they can quickly 
respond to changing conditions, assuring that the most appropriate genes and pro-
teins are transcribed and synthesized at the precise amount at any given time. 
To sense changes to the extracellular environment, bacteria commonly use 
sensory systems known as two-component signal transduction (2CST) pathways. As 
the name implies, the simplest of these pathways consists of only two components: a 
sensor kinase (SK) and a response regulator (RR) (Fig.1 Left). The SK is a histidine 
kinase that autophosphorylates a conserved histidine (His) residue using ATP as its 
phosphoryl donor. Once phosphorylated, the SK serves as the phosphoryl donor to 
its cognate RR, an aspartyl kinase that autophosphorylates a conserved aspartate 
(Asp) residue located in its receiver domain [reviewed in (127)]. In general, the 
more complex the environment in which a bacterial species lives, the greater the 
number of 2CST pathways encoded by its genome (16). 
In addition to constantly monitoring their extracellular environment, bacte-
ria must also closely monitor their intracellular environment, as such monitoring 
provides important information concerning nutritional status. This nutritional in-
formation allows a bacterial cell to ‘decide’ how much energy it can invest in differ-
ent physiological processes and ultimately decide whether the cell should remain 
metabolically active or become quiescent (61).  
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The cells can receive cues concerning their nutritional status by monitoring 
the ratios and/or concentrations of important molecules, such as NAD+/NADH, 
ATP/ADP, cAMP and ppGpp. The information obtained from the ratios and/or con-
centrations of these different molecules must be integrated with signals that are be-
ing received from the extracellular environment. Proper signal integration should 
promote the most adequate amount of expression and activity of the proteins most 
suited for survival at that specific environmental condition. One of the many ways 
by which bacterial cells can integrate large amounts of constant and diverse sensory 
information is posttranslational modification of proteins, especially of proteins in-
volved in signal transduction and proteins involved in the transcriptional machinery 
that convert the signal into action. 
My dissertation focuses on the mechanism by which one signaling pathway 
of Escherichia coli, the CpxAR 2CST system, integrates intracellular cues to regulate 
the cpxP promoter, which drives expression of a chaperone that respond to 
periplasmic stresses, such as unfolded proteins. The data I will provide here sup-
ports a model in which the CpxAR pathway utilizes intracellular information to 
modulate cpxP transcription via an acetylphosphate (AcP)-dependent phosphoryla-
tion of the RR CpxR and AcP-dependent acetylation of RNA polymerase (RNAP).  
During the next few pages, I will provide a brief overview of 2CST and the 
CpxAR pathway. I will then provide some background information on AcP and Ace-
tyl-Coenzyme A (AcCoA), followed by an overview of the current understanding of 
5 
 
 
 
protein acetylation. I will end with an explanation of RNAP and the steps involved in 
transcription initiation. 
   
TWO-COMPONENT PATHWAYS 
Two-component signal transduction (2CST) pathways are sophisticated sen-
sory systems found in bacteria, archaea and a few eukaryotic organisms (127). 
These systems help organisms sense and mount a response to changes in their envi-
ronment. The classic 2CST pathway contains only two proteins, a sensor kinase pro-
tein (SK) and a cognate response regulator (RR) (Fig. 1 left). The SK is often but not 
always integral to or associated with the cellular membrane (12). The RR is often 
but not always involved in transcriptional regulation and thus often but not always 
will contain a DNA-binding domain (41, 42). 2CST proteins are modular and, in gen-
eral, RRs possess two independent domains while SKs contain two highly conserved 
domains, a dimerization and histidine phosphotransfer (DHp) domain and the cata-
lytic and ATP binding (CA) domain, and at least one and sometimes several addi-
tional domains (40). 2CST pathways also can be made of more than two proteins 
(Fig. 1 right), adding complexity to the transfer of information from the SK to the 
RR as it increases the number of domains and/or proteins that are involved in the 
signal transduction; thus, increasing the number of places on the pathway in which 
the transfer of information can be regulated (12). For the purpose of this disserta-
tion, henceforth, I will focus on the less complex and more orthodox form of these 
2CST pathways. 
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Many organisms encode multiple 2CST that are involved in sensing different 
environmental signals. In general, 2CST pathways share a large degree of homology 
among each other.  Thus, many mechanisms are in place to prevent an erroneous 
transduction of signal between non-cognate 2CST pathways, also known as cross-
talk. In order to achieve this specificity, cognate SKs and RRs are thought to have co-
evolved to incorporate specificity residues along the surface or regions used for 
their interaction. These residues decrease the rate of phosphoryl transfer among 
non-cognate proteins, while maintaining a high transfer rate among cognate pro-
teins [reviewed in (100)].  
The relay of information from the SK to the RR, leading to the final output, 
requires multiple phosphoryl transfers.  It initiates with the transfer of phosphoryl 
groups from the γ phosphoryl group of ATP to a conserved His side chain on the SK. 
This transfer of phosphoryl group from ATP to the conserved His side chain of the 
SK is mediated by conserved residues on the ATP-binding domain of the SK. Once 
phosphorylated, the phosphorylated SK serves as the phosphoryl donor to its cog-
nate RR, which autocatalyzes the phosphorylation of a conserved Asp side chain on 
the surface of its own receiver domain. This phosphotransfer from the SK to the RR 
requires divalent metal ions and Mg2+ is thought to be the prevalent cation used in 
vivo. Phosphorylation of the conserved Asp residue leads to a conformational 
change in the RR, allowing it to alter the molecular interaction(s) by which the re-
sponse is achieved. The final phosphotransfer occurs from the phosphorylated Asp 
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to water via hydrolysis, bringing the RR back to its unphosphorylated 
state[reviewed in (127)].  
The half-life of phosphorylated RRs vary drastically, but typically ranges 
from a few second to hours (51). However, there are some exceptions. For example, 
the yeast response regulator SSK1 has a half-life of approximately 2 days (59). Sev-
eral factors contribute to this short half-life: (i) phospho-Asp possesses an intrinsic 
instability which favors its unphosphorylated state (1); (ii) many RRs possess auto-
phosphatase activity, which helps increase the rate of dephosphorylation (51); and  
(iii) Many SKs also contain phospho-Asp phosphatase activity, which is also thought 
to contribute to the dephosphorylation rate of their cognate RRs [reviewed in (43, 
74)]. This phospho-Asp phosphatase activity has been demonstrated both in vivo 
and in vitro for many SK. However, in some cases, it has been proposed that the 
phosphatase rate is too slow for it to be relevant in vivo (66). 
 
THE CpxAR TWO-COMPONENT SIGNAL PATHWAY 
 The E. coli K-12 genome encodes 30 SKs and 32 RRs (93). The RR CpxR and 
its cognate SK CpxA constitute the 2CST pathway CpxAR (Fig. 2). This signal path-
way is highly conserved in the family Enterobacteriaceae and can be found in some 
other Proteobacteria. In E. coli, the CpxAR pathway regulates transcription of at 
least 50 genes (29, 102), including genes that control part of the envelope stress re-
sponse system, pilus assembly, type III secretion, motility and chemotaxis, adher-
ence, and biofilm development. Furthermore, the CpxAR pathway is required for in-
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vasion of host cells in diverse pathogenic bacteria, including E. coli (enterohemor-
rhagic E. coli and uropathogenic E. coli), Salmonella enterica serovar Typhimurium, 
S. enterica serovar Typhi, Shigella sonnei, Yersinia enterocolitica, Heamophilus du-
creyi and Legionella pneumophila [for reviews, see references (31, 32, 106, 109, 110, 
115, 122)]. A recent study demonstrated that Xenorhabdus nematophilus requires 
the Cpx pathway both to colonize its nematode host (Steinernema carpocapsae) and 
to kill larvae of the tobacco hornworm (Manduca sexta). In L. pneumophila, the 
pathway regulates the type IV bundle-forming pilus (BFP) and some components of 
type IV secretion, respectively [reviewed in (137)]. BFP assembly is also affected by 
the CpxAR system in enteropathogenic E. coli (EPEC). In this organism, a deletion of 
CpxR decreased BFP and affected its ability to adhere to epithelial cells (97). 
The CpxAR is an autogenously regulated 2CST pathway. CpxA, a SK with au-
tokinase, phosphotransfer, and phospho-CpxR phosphatase activities (36, 111), is 
located in the cytoplasmic membrane, where it senses diverse signals, including al-
kaline pH, altered membrane lipid composition, interaction with hydrophobic sur-
faces, and misfolded pilin subunits, as well as exposure to copper, detergents, and 
EDTA. In response to these different stimuli, CpxA autophosphorylates and serves as 
a donor of phosphoryl groups to CpxR, the cognate RR. By analogy to the RR OmpR, 
CpxR phosphorylation is thought to occur on the conserved Asp-51 residue on its 
receiver domain. 
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The CpxR pathway includes at least two more upstream components. The 
first additional component, CpxP, was identified as an alkaline-induced member of 
the Cpx regulon (23). This periplasmic chaperone binds to the periplasmic domain 
of CpxA and inhibits its autokinase activity (36, 107, 108). It appears that CpxP 
binds to specific features of certain misfolded proteins, making them available to the 
ATP-independent periplasmic protease DegP. Since CpxP is degraded along with its 
cargo, misfolded proteins in the periplasm enhance the probability that CpxA will 
function as a kinase and initiate the phosphotransfers that will end with activation 
of the Cpx regulon including CpxP (11, 30, 54, 77). The second component, the outer 
membrane lipoprotein NlpE, activates CpxA when it is overexpressed (120), and it is 
required for activation of CpxA in response to adherence to hydrophobic surfaces 
(98). Since adhesion requires NlpE, but not CpxP, and since stresses that require 
CpxP do not require NlpE (23, 30, 98), CpxA must integrate information from at 
least these two distinct stress response pathways (30, 107). Furthermore, it is likely 
that additional upstream components exist (107). For example, CpxA and CpxR-
dependent resistance to copper exposure requires neither CpxP nor NlpE (151). 
In the absence of its extracytoplasmic stimuli, CpxA is reported to function as a net 
phosphatase, removing phosphoryl groups from phospho-CpxR (85, 111, 149). Like 
many RRs, purified CpxR can accept a phosphoryl group from AcP (101, 111). AcP, 
the high-energy intermediate of the phosphotransacetylase (Pta)-acetate kinase 
(AckA) pathway (Fig. 3), has a larger ΔG° of hydrolysis (-43.3 kJ/mol) than ATP (-
30.5 kJ/mol in complex with Mg2+). This large amount of energy stored by AcP is 
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crucial for its role as a global signaling molecule, as this energy is capable of 
inducing the conformational changes required for activation of RRs (60, 129). The 
phospho-Asp phosphatase activity of CpxA, therefore, could function to prevent 
inappropriate AcP-dependent activation of CpxR. In this dissertation I will address 
these issues by testing if CpxA possess phosphatase like-activity in vivo, and wheth-
er AcP function as a phosphoryl donor to CpxR in vivo. 
 
PTA-ACKA PATHWAY AND ACETYLPHOSPHATE 
Reversible in vivo, the Pta-AckA pathway interconverts coenzyme A (CoA), 
ATP, and acetate with acetyl-CoA (AcCoA), ADP, and inorganic phosphate (Pi). This 
reversibility permits both AcCoA synthesis (acetate activation) and acetate evolu-
tion (acetogenesis) (Fig. 3). During acetogenesis, Pta synthesizes AcP and CoA from 
AcCoA and Pi, while AckA generates ATP from AcP and ADP. 
Simultaneously, AckA produces acetate, which cells freely excrete into the 
environment. Thus, the steady-state concentration of AcP depends on the rate of its 
formation catalyzed by Pta and the rate of its degradation catalyzed by AckA [re-
viewed in (145)]. Acetogenesis has several key functions. It recycles CoA, facilitating 
glycolytic flux and hence rapid growth in the presence of an excess of a preferred 
carbon source (e.g., glucose or pyruvate) [reviewed in (145)]. This function also can 
reinitiate stalled tricarboxylic acid (TCA) cycle function, providing CoA to convert α-
ketoglutarate to succinyl-CoA (35). Critically, acetogenesis provides the majority of 
ATP in the absence of robust TCA cycle activity (145). 
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However, the conversion of AcCoA to acetate and ATP often does not go to 
completion; E. coli cells can and do maintain a significant pool of AcP (72, 90, 104). 
This pool serves the cell in two distinct and equally important ways. First, AcP 
serves as a storage molecule for carbon (C), phosphate (OPO3), and energy in the 
form of its high-energy COOPO3 bond (92). Second, AcP can serve as a signaling 
molecule [reviewed in (146)]. 
 In the early 1990s, AcP was proposed to act as a global signal by donating its 
phosphoryl group to a subset of RRs (91, 141). Intracellular AcP concentration var-
ies in response to the environment. AcP concentrations can be as high as 4 to 5 mM 
in wild-type (WT) cells and 15 to 20 mM in ackA mutants (72). These concentrations 
are sufficient to induce in vitro phosphorylation of some RRs (84). 
 Much evidence now exists to support the hypothesis that AcP-dependent 
phosphorylation of a subset of RRs contributes to their function in vivo [reviewed in 
(146)]. For example, the RR RcsB can be induced to activate capsule biosynthesis 
and repress flagellar biogenesis in an AcP-dependent manner (38). Genetic evidence 
in support of this proposition was obtained using epistasis analysis. By combining 
mutations in the Pta-AckA pathway with mutations in the Rcs 2CST pathway and 
then comparing the phenotypes of the resultant double mutants to those of the pa-
rental single mutants, Fredericks et al. were able to conclude that AcP acts via RcsB 
to activate genes for encapsulation and to repress genes for flagellation (38). This 
well-characterized DNA-binding RR controls about 5% of the E. coli genome [re-
viewed in (87, 103)] and as much as 20% of the S. enterica genome (140), including 
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many genes involved in virulence. Thus, AcP influences expression of multiple genes 
through a known global regulator. 
 While many behaviors associated with disruption of the Pta-AckA pathway 
correlate with AcP concentrations, some do not [reviewed in (146)]. If a behavior 
strictly depends on AcP to donate its phosphoryl group to a response regulator, then 
an ackA mutant, which accumulates AcP (72), should elicit a behavior opposite to 
that exhibited by a pta mutant, which cannot synthesize AcP (72). However, that is 
not always the case. This lack of correlation could be due to a lack of involvement of 
AcP, or perhaps because disruption of the Pta-AckA pathway can have more plei-
otropic effects on central metabolism. For example, disruption of the Pta-AckA 
pathway is likely to affect the flux of acetyl groups through central metabolism [re-
viewed in (144)]. 
 
ACETYL-COENZYME A 
AcCoA plays a very important role in cellular metabolism (Fig. 4) . It contrib-
utes to fatty acid biosynthesis and serves as the carbon donor to the TCA cycle by 
donating its acyl group to oxaloacetate. This transfer of acetyl groups recycles CoA 
[reviewed in (144)], the major acyl group carrier in living systems (78). E. coli pro-
duces limiting amounts of CoA, and growth arrest initiates once the CoA concentra-
tion falls below 5 pmol/108 cells (58). Therefore, cells must recycle CoA to maintain 
proper glycolytic flux and therefore growth. 
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Similar to AcP, AcCoA concentration has been shown to fluctuate and rapidly 
increase when E. coli cells are exposed to some carbon sources like glucose (135). 
This increase in AcCoA concentration has the potential to put stress on the limited 
CoA pool, potentially leading to metabolic imbalance. When combined with disrup-
tion of the Pta-AckA pathway, this imbalance could drastically affect cellular physi-
ology. 
 
ACETYLATION 
 Protein acetylation is typically thought of as the transfer of an acetyl group 
from an acetyl donor, e.g. AcCoA, to a protein. This transfer can occur either at the 
amino terminus of a protein (Nα) or to the ε-amino (Nε) group of a lysine residue 
(Fig. 5). This transfer is often mediated by an acetyltransferase that can establish 
the proper catalytic microenvironment. The acetyltransferase acts as a scaffold, ori-
enting the acetyl group of AcCoA and the amino group of the acceptor protein into 
close proximity. The enzyme then promotes deprotonation of the amino group, cre-
ating a neutral amino group that serves as a nucleophile that attacks the carbonyl 
carbon of AcCoA, acetylating the protein and releasing a free CoA molecule (33).  
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Nα-acetylation is considered to be an irreversible modification of either the 
deformylated N-terminal methionine or, following cleavage of the N-terminal me-
thionine, the newly exposed amino acid. In eukaryotes, Nα-acetylation of proteins is 
extremely common (present on more than 80% of mammalian proteins) and is pri-
marily cotranslational. In bacteria, Nα-acetylation is proposed to be less common, 
occurring post-translationally on ribosomal proteins [reviewed in (53)]. 
In contrast to Nα-acetylation, Nε-acetylation is both dynamic and reversible. 
This property permits Nε-acetylation to serve in as regulatory mechanism. The im-
pact of Nε-acetylation varies according to the context. Nε-acetylation can change the 
size, charge and/or conformation of the protein. These changes can alter DNA bind-
ing affinity, protein stability, protein–protein interactions, protein localization and 
protein function. Nε-acetylation is also known to influence other post-translational 
modifications [reviewed in (46, 152)], a process known as PTM crosstalk. In general, 
evidence of PTM crosstalk is more prevalent in eukaryotic organisms. For example, 
gene expression can be regulated at the level of chromatin structure. Numerous res-
idues within the histone tails and several residues within the histone globular do-
mains can be modified in a variety of ways, including acetylation, phosphorylation, 
ubiquitination, and methylation[reviewed in (76)]. The combination of these modi-
fications, depending to the context, can act to facilitate or repress transcription. In 
some cases the modification of one residue can alter the ability of a second residue 
to be implemented by its modifying enzyme(s). For example, phosphorylation of 
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serine 10 on histone H3 stimulates the ability of Gcn5 to acetylate histone H3 at ly-
sine 14 (H3K14) (19, 86). A second example of PTM crosstalk in eukaryotes can be 
seen with CTD of eukaryotic RNA polymerase II which has been shown to be both 
phosphorylated and glycosylated. The pattern or glyscosylation and/or phosphory-
lation affect the ability of some proteins to interact with RNAP II. Although both gly-
cosylation and phosphorylation can occur on RNAP II CTD, phosphorylation seems 
to prevent glycosylation [reviewed in (34)]. The evidence is less extensive that PTM 
cross-talk occurs in bacteria; however, multiple proteins have been shown to be 
modified by more than one PTM [reviewed in (121)]. For example, the RRs RcsB and 
CheY have been shown to be both phosphorylated and acetylated and evidence ex-
ists to support the hypothesis that the function of these proteins is affected by both 
PTMs (82, 132). While it remains to be determined whether either PTM can affect 
the other, some evidence exists that in vitro phosphorylation of RcsB might be af-
fected by its acetylation (Hu, L. I. and Wolfe, A. J. unpublished) 
Acetylation of non-lysine residues also has been shown to occur. In bacteria, 
Ser/Thr acetylation is known to have a role in virulence. For example, Yersinia pestis 
blocks host defense pathways in the inflammatory response by acetylating serine 
and threonine residues that are essential in MAPK/NF-κB signaling pathways (94). 
Salmonella enterica utilizes a similar mechanism during host invasion (63). 
 Unless otherwise mentioned, for the remainder of this section, I will focus of 
the reversible Nε-Acetylation. 
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 While in eukaryotic cells, protein acetylation has been extensively studied, in 
bacteria and archaea this has not been the case. Until recently, our knowledge of 
protein acetylation in bacterial cells was limited to the acetylation of acetyl-CoA syn-
thetase (an enzyme that converts acetate to AcCoA) and CheY (a signal protein cen-
tral to chemotaxis) [reviewed in (53, 131)]. However, recent global proteomics stud-
ies have provided evidence that protein acetylation is widely prevalent in E. coli 
(155, 157), S. enterica (139) and more recently B. subtilis (68). These studies indi-
cate that Nε-lysine acetylation might be as prevalent in bacteria as in eukaryotes. 
In parallel with what has been reported for eukaryotic cells, protein acetyla-
tion in bacteria is thought to be regulated and reversible [reviewed in (53, 130)]. 
Protein acetylation is thought to be mediated by proteins with lysine acetyltransfer-
ase activity (KAT), while deacetylation is thought to be mediated by proteins with 
lysine deacetylases (KDACs) 
Up to five groups of proteins with KAT activity have been identified: (i) the 
Gcn5-related acetyltransferase (GNAT) family, (ii) the MYST family, (iii) the 
CBP/p300 co-activators, (iv) the SRC family of co-activators and (v) the TAFII group 
of transcription factors [reviewed  in (88, 126)].  
Of the five groups of proteins with acetyltransferase activity, the GNATs are 
the most widely distributed, with over 10,000 members identified across all three 
domains of life [reviewed in (136)]. Importantly for bacteriologists, GNATs are 
ubiquitous within the bacterial domain and are capable of carrying out a diverse 
range of functions. Some GNATs, such as protein acetyltransferase (Pat) from S. en-
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terica, catalyse Nε-acetylation (124), while other GNATs are reported to perform 
Nα-acetylation; for example RimI, RimL and RimJ of E. coli (128, 154).  
Not all GNATs catalyse protein acetylation. Indeed, the first characterized 
members of the GNAT family, the aminoglycoside N-acetyltransferases, were dis-
covered as bacterial enzymes that could acetylate and thus inactivate antibiotics 
[reviewed in (27, 118)]. 
In addition to this acetyltransferase mediated acetylation of proteins, auto-
acetylation, an intramolecular covalent modification, has also been reported for sev-
eral eukaryotic KATs [Tip60 (138) and p300 (133) for example] and for the E. coli 
proteins acetyl-CoA synthetase (ACS) and CheY (4). Unpublished evidence from the 
Wolfe laboratory adds the RR RcsB and the central metabolism protein LpdA to the 
list of proteins that appear to autoacetylated (Linda I. Hu, Bui Khanh Chi, Misty L. 
Kuhn, Ekaterina V. Filippova, Arti J. Walker-Peddakotla, Katrin Bäsell, Dörte Becher, 
Wayne F. Anderson, Haike Antelmann, and Alan J. Wolfe unpublished data).  
 Two major families of KDACs have been identified. These two families have 
been grouped into four classes (49): the zinc-dependent Rpd3/Hda1 family (classes 
I, II and IV) (153) and the NAD+-dependent sirtuin family (class III) (8). For each 
KDAC class, putative bacterial homologues have been identified [reviewed in (52)], 
but only a few have been shown to serve as protein deacetylases and very few of 
their protein substrates have been identified (44, 45, 52, 79, 123, 139). 
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RNA POLYMERASE AND TRANSCRIPTION INITIATION 
 The E. coli genome encodes approximately 4500 open reading frames (ORF). 
However, the number of RNAP subunits available for transcription is less than half 
of that, about 2000 units per cell [reviewed in (55)]. Thus, a large effort is invested 
in the decision as to which promoter(s) will be engaged by RNAP, and thus which 
genes will be transcribed. Because RNAP is a limited resource, transcription initia-
tion is the major regulatory mechanism used to regulate genomic expression in bac-
teria. 
 RNAP is a large multi-subunit complex. Its core (E) is composed of 5 highly 
conserved subunits, α2ββ’ω, with homologues found in all domains of life. Although 
this core enzymatic complex is capable of synthesizing RNA polymers, its ability to 
bind DNA requires interaction with one of the seven σ factors encoded by the E. coli 
genome. The complex formed by E and one of the σ factors is called RNAP holoen-
zyme (Eσ). In E. coli, σ70, encoded by rpoD, is the most abundant σ factor and it is re-
quired for transcription of most ORFs [reviewed in (50, 56)].  
Although σ70 is the most abundant σ factor in E. coli, the cellular concentra-
tions of the σ factors are very dynamic. It varies with different growth phases and 
environmental conditions (55, 57). This change in steady state levels of σ factors 
will, consequently, change the probability that E will interact with a particular type 
of σ factor. Since different promoters, or groups of promoters, possess binding ele-
ments that favor the binding of different σ factors, the concentration of the sigma 
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factors will dictate the genes that can be transcribed at any given time [reviewed in 
(50, 56, 114)].  
 After interaction with one of the σ factors, the Eσ complex is now capable of 
interacting with a promoter region. The complex DNA-Eσ is termed RNAP closed 
complex (RPc). After the initial promoter interaction, the next step in transcription 
initiation leads to melting of the double stranded DNA and the formation of a tran-
scription bubble that begins at a nucleotide hexamer known as the -10 element, be-
cause it is located approximately 10 nucleotides upstream of the transcription start 
site, which is also included in the transcription bubble. This complex is known as the 
open complex (RPo). With the exception of Eσ54, the energy required to drive the 
melting of the double stranded DNA comes from large conformational changes in Eσ 
and DNA and not from ATP hydrolysis or the hydrolysis of any other energy filled 
metabolite. Once the open complex is formed, NTP incorporation drives the tran-
scription reaction forward. This step is known at the transcription initiation com-
plex (TIC). However, at most promoters, RNAP synthesizes short, abortive products 
before transitioning to the elongation complex (TEC). During this time, the leading 
edge of σ and the active site of the enzyme move forward, but the contacts between 
the trailing edge of RNAP and the nucleotide hexamer located approximately 35 nu-
cleotides upstream of the transcription initiation site(–35 hexamer) remain intact. 
Transcription elongation occurs once Eσ breaks its contact with the promoter re-
gion and progresses downstream. Eventually, the interaction between E and the σ 
factor also breaks and σ releases to interact with another E (50). Although a large 
24 
 
 
 
amount of molecular information is known about the Eσ70 closed and open com-
plexes, not much is known about the intermediate stages [reviewed in (50, 56, 114, 
147)]. 
  Availability and interaction with the different σ factors is only one of the 
many factors determining transcription initiation. Further selectivity is achieved by 
interaction of Eσ with one of the approximately 300 transcription factors in E. coli. 
While most of these transcription factors contain DNA-binding elements, approxi-
mately 10% of them interact directly with RNAP, regulating transcription elongation 
and termination (57). Similarly to σ factors, the concentration of these transcription 
factors is affected by growth phases and environmental conditions, as well as nutri-
tional status. In general, the vast majority of these transcription factors are present 
in very small concentrations, usually less than 100 molecules per cell. Most tran-
scription factors possess very weak affinity for RNAP, which in some cases can be 
altered via a covalent posttranslational modification or a non-covalent interaction 
with a ligand. It is important to mention that although some of these modifications 
can increase the affinity between transcription factors and RNAP, the overall affinity 
between them must remain relatively weak to allow for a quick turnover of tran-
scription factor that interacts with RNAP. This relatively weak interaction is also re-
quired to facilitate promoter clearance, as a complex that is too stable will have dif-
ficulty breaking free from the many interactions formed at the promoter level, and 
will be less likely to progress into transcription elongation [reviewed in (50, 56)]. 
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 In addition to binding elements for σ factors, and in some cases binding sites 
for some transcription factors, some promoters may also contain a stretch of adeno-
sines (A) and thymidines (T) upstream of the σ factor interaction site. This AT-rich 
stretch, termed the UP-element, can serve as an additional stability point as the car-
boxy-terminal domain of the α subunit of RNAP (αCTD) can make direct contact to 
this region (48, 113).  
The α subunit is composed of two independently folded domains tethered by 
a flexible linker region of approximately 15 amino acids (9). Dimerization of the 
amino-terminal domain (αNTD) is the nucleating step for E assembly (156), while 
the CTD directly interacts with DNA, in and across a minor groove, via a helix-
hairpin-helix motif (7, 48, 112). 
The UP-element is widely distributed in bacteria, plasmids and phages. Ge-
netic and biochemical analysis of the interaction between αCTD and the UP-element 
in the rrnB promoter has identified a crucial patch of amino acids (Arg-265, Asn-
294, Gly-296, Lys-298 and Ser-299) on the αCTD, known as the 265 determinant, 
that is required for DNA interaction (7, 112). This information has been confirmed, 
at the atomic level, by X-ray structure analysis of the interaction between αCTD and 
the UP-element on the lac promoter (7). In addition to directly interacting with DNA, 
the 265 determinant has been shown to be directly involved in a protein-protein in-
teraction between αCTD and the transcription elongation protein NusA (116).
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CHAPTER TWO 
MATERIALS AND METHODS 
BACTERIAL STRAINS, BACTERIOPHAGE AND PLASMIDS 
All bacterial strains used in this study are listed in Table 1. Derivatives were 
constructed by generalized transduction with P1kc (for details, see Generalized P1 
transduction). The transcriptional fusion ϕ(PcpxP’-lacZ) carried by λPcpxP was a 
generous gift from Thomas Silhavy (Princeton University, Princeton, NJ). All plas-
mids used in this study are listed on Table 1. Derivatives were constructed either via 
cloning or by site-directed mutagenesis (for details, see Plasmid Construction and 
Site-Directed Mutagenesis).
 
CULTURE CONDITIONS 
For strain construction, cells were grown in Luria Broth (LB) containing 1% 
(wt/vol) tryptone, 0.5% (wt/vol) yeast extract, and 0.5% (wt/vol) potassium chlo-
ride; LB plates also contained 1.5% agar. For promoter activity assays, cells were 
grown in tryptone broth containing 1% (wt/vol) tryptone and 0.5% (wt/vol) potas-
sium chloride. Potassium chloride was used instead of sodium chloride because so-
dium has a negative effect on the survivability of WT cells at alkaline pH (64). For 
some experiments, the medium (liquid or solid) was buffered with base and acid to 
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a final concentration of 100 mM at ratios required to achieve the desired pH. No KCl 
was added to TB when a potassium-based buffer was used to adjust the pH. Cell 
growth was monitored spectrophotometrically (DU640; Beckman Instruments, 
Fullerton, CA) by determining the optical density at 600 nm (OD600). 
Antibiotics were prepared as a stock solution 1000 times the working con-
centration. Working concentrations were as follows: ampicillin, 100 μg/mL; kana-
mycin, 40 μg/mL; spectinomycin 100 μg/mL; tetracycline, 15 μg/mL and chloram-
phenicol, 25 μg/mL. Stock solutions of ampicillin, kanamycin and spectinomycin 
were dissolved in water and filter sterilized. Stock solutions of tetracycline and 
chloramphenicol were dissolved in 50% and 100% ethanol, respectively, and filter 
sterilized. All antibiotic stocks were stored at -20°C. When necessary, isopropyl β-D-
1-thiogalatopyranoside (IPTG) was added to the media at the indicated concentra-
tion to induce gene expression from a plasmid vector. Nile red (Sigma Aldrich), at a 
final concentration of 25 µg/ml, was added to LB plates to detect in vivo PHB accu-
mulation. PHB detection using Nile red will be explained later. 
 
GENERALIZED P1 TRANSDUCTION 
A single colony was inoculated in TB and grown overnight at 37°C aerobically 
with agitation at 250 RPMs. In the morning, 50 μL of overnight culture were added 
to 5 mL of TB for transduction (TBT) (0.2% [wt/vol] glucose from a 20% [wt/vol] 
stock solution, 10 mM CaCl2, 10 mM MgSO4, and 0.4 mM FeCl3 in TB). The overnight 
culture was grown in TBT until it reached an OD600 of approximately 0.5. One mL of 
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cells was infected with 10-100 μL of phage lysate and incubated statically at 37°C for 
30 minutes. After incubation, 200 μL of 1M sodium citrate (pH 5.5) were added to 
prevent a second round of phage absorption. The cells were pelleted using a table-
top centrifuge at 16000 RCF for 1 minute at room temperature. The supernatant 
was decanted and the pellet resuspended with 500 μL LB and 200 μL 1M sodium 
citrate. The cells were then incubated aerobically at 37°C with agitation at 250 RMP 
for 70 minutes to give them time to develop antibiotic resistance. After the second 
round of incubation, the cells were pelleted as described before. The supernatant 
was decanted and the pellet was resuspended with 50 μL 1 M sodium citrate. The 
entire cell suspension was plated onto LB agar plates with appropriate antibiotics 
required for the desired selection. 
 
PLASMID CONSTRUCTION 
Plasmids pPHB1 and pPHB3. These plasmids were constructed by Shaun R. Brins-
made (UW-Madison).  Alleles phbCAB+ were amplified from Ralstonia solanacearum 
strain GMI1000 (a kind gift from Caitilyn Alen, UW-Madison) using forward primer 
5’—ATC GAA CCC GGG ATG GCA TCG CGT CAC AA—3’ and reverse primer 5’—AGC 
ATG AGT GCC CCG GGT CAG CCC ATG T—3’. Bases underlined indicate the SmaI re-
striction site engineered into each primer.  The resulting ~4-kb fragment was A-
tailed and gel-purified using the QIAquick gel extraction kit (Qiagen). This product 
was ligated into the multiple cloning site of plasmid pGEM-T-Easy (Promega).  The 
resulting plasmid was ~7-kb. From this plasmid, named pPHB1, the Rs phbCAB+ 
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genes were cut out using SmaI.  The resulting ~4-kb fragment was gel-extracted and 
ligated into plasmid pTAC-85 (89) that had been cut with NcoI and the resulting sin-
gle-stranded DNA overhangs blunted with mung bean nuclease and dephosphory-
lated using shrimp alkaline phosphatase.  The resulting plasmid was ~9.1-kb and 
was named pPHB3. 
 
Plasmid pBPL001. The WT cpxR allele was amplified from pCA24n-CpxR using pri-
mers cpxRFNdeI (5’-GGTATTTAACATATGAATAAATCCTG-3’) and cpxRRHindIII (5’-
GGTATTTAACATATGAATAAAATCCTG-3’). The resulting amplicon was ligated into 
pJET1.2, using the CloneJETTM PCR Cloning Kit (Fermentas). The ligated product was 
cut out of pJET1.2 with NdeI and HindIII, gel-extracted, ligated into pET28 down-
stream of the IPTG-inducible promoter, and fused to a C-terminal His6 tag. The re-
sulting plasmid was named pBPL001. 
 
Plasmid p770-cpxP. This plasmid is a derivative of p770 (a generous gift from Rick 
Gourse at the University of Wisconsin-Madison). It is an ampicillin-resistant ColE1-
based plasmid that has the tandem rrnB operon terminators T1 and T2 located 
downstream of the insertion sites for the promoter. The cpxP promoter region was 
amplified from strain BW25113 with the following primer pair: cpxP’FEcoRI (5’-
AATAGGGAATTCAGTTCTCGGTCATC-3’) to insert the EcoRI site upstream of the 
promoter region and cpxP’RHinDIII (5’-GCAGCGAAGCTTAATGAACTGACTG-3’) to 
insert the HinDIII site downstream. The resulting amplicon was ligated into pJET1.2, 
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using the CloneJETTM PCR Cloning Kit (Fermentas) following kit instructions. The 
ligated cpxP insert was sequenced, digested out of pJET1.2 with EcoRI and HindIII, 
and gel-extracted. The gel-extracted fragment was cloned into previously digested 
p770 via overnight ligation at room temperature. Ligated plasmids were trans-
formed into E. coli DH5α cells. Plasmids were recovered from transformants and re-
striction digested to screen for the presence of the cpxP promoter. The presence of 
the promoter was confirmed via sequencing analysis. The plasmid containing the 
correct insert was purified, stored at -20°C and named p770-cpxP. 
 
SITE DIRECTED MUTAGENESIS 
Site directed mutagenesis of plasmids pBPL001, pIA900 and pREII was con-
ducted using Agilent Technologies’s QuickChange Site-Directed Mutagenesis Kits, 
according to manufacturer’s instructions. The mutations were confirmed by se-
quence analysis of the purified mutagenized plasmids. 
 
TRANSFORMATION 
Two distinct transformation methods were used: TSS and electroporation. 
TSS – 1 ml of overnight cell culture was pelleted at room temperature for 1 minute 
at 16000 RCF using a table-top centrifuge. The pellet was resuspended with 100 µl 
TSS [10% (wt/vol) poly(ethylene glycol), 5% (vol/vol) DMSO and 50 mM MgSO4 or 
MgCl2 in LB]. After resuspension, 50 ng of plasmid DNA was added to the resus-
pended cells, the mixture was incubated on ice for 30 minutes.  After ice incubation, 
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0.9 mL of LB was added, and the cells were incubated for 1 hour at 37°C with aera-
tion. After 37°C incubation, the cells were pelleted one more time as described 
above, the supernatant was decanted, and the cells were resuspended in 250 μL LB. 
25-100 µl of the resuspended cells were used for plating on an LB agar plate con-
taining the appropriate antibiotic for selection. 
 
Electroporation - For electroporation, the recipient cells were made competent by 
inoculating 30 mL of LB in a 250 mL baffled flask with 500 µL of overnight culture. 
The culture was incubated with aeration rotating at 250 RPM at 37°C until OD600 
reached 0.4-0.6. The culture was split into two Oakridge tubes and spun down at 
10000 RCF for 10 minutes at 4°C. After pelleting the cells, the supernatant was aspi-
rated, and the cell pellet was resuspended with 1 mL of ice-cold sterile water. After 
resuspension, an additional 9 mL of ice cold water was added to the tube, bringing 
the total volume to 10 mL and the cells were spun one more time at 10000 RCF for 
10 minutes at 4°C. At the end of the second spin, the supernatant was gently decant-
ed immediately, as the pellet is not very compact and stable at this point. The pellet 
then was resuspended one more time with 1 mL of ice cold water, transferred to a 
1.5 mL eppendorf tube, and spun down at 16000 RCF for 1 minute, using a table top 
centrifuge at room temperature. The supernatant then was aspirated one more time, 
the pellet was resuspended with 200 µl of water, divided into 50 µl aliquots and 
stored at -80°C for future use. 
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Transformation began by mixing 50 ng of purified plasmid DNA with 50 µL of 
electro-competent cells. The DNA-cell mixture was then transferred to a 1 mm 
chilled electroporation cuvette and electroporated at 1.8 KV. After electroporation, 
the cells were immediately rescued by the addition of 1 mL of LB, transferred to a 
small test tube, and incubated at 37°C, rotating at 250 RPM for 1 hour. After incuba-
tion, 20-100 µL of cells were plated onto LB agar plates containing the appropriate 
concentration of antibiotic required for selection of transformants. Outgrowth was 
often, but not always, carried out overnight at 37°C. 
 
PROMOTER ACTIVITY ASSAY 
To monitor promoter activity from ϕ(PcpxP’-lacZ), cells were grown aerobi-
cally with agitation at 250 rpm at 37°C in TB that was unbuffered or TB that was 
buffered either at pH 7.0 (TB7) or at pH 8.0 (TB8). At regular intervals, 50 µL ali-
quots were harvested and added to 50 µL of All-in-One β-galactosidase reagent 
(Pierce Biochemical). β -galactosidase activity was determined quantitatively with 
the Y-PER β-galactosidase assay kit (Pierce Biochemical), using a microtiter format. 
Promoter activity was plotted versus OD600. For some experiments, only the peak 
activity is shown. Each experiment included three independent measurements and 
was repeated at least once. 
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pH SENSITIVITY ASSAY 
Cells were grown aerobically with agitation at 250 rpm at 37°C in LB buff-
ered at pH 7.0 (LB7) until either mid-exponential phase or early stationary phase, 
harvested, serially diluted in LB7, and plated onto LB plates buffered at the specified 
pH. The plates were incubated overnight at 37°C, the colonies were counted, and the 
colony diameters were measured. 
 
NILE RED 
Nile Red was used to detect the production and accumulation of polyhy-
droxybutyrate (PHB) on LB agar plates by E. coli cells carrying plasmid pPHB3. A 
single colony was streaked onto LB agar plate containing Nile Red at a final concen-
tration of 0.5 µM/ml, 50 µM IPTG to induce PHB expression and 25 µg/ml ampicillin 
to force the cells to maintain the plasmid. The plates were incubated overnight at 
37°C. After incubation, PHB accumulation was detected by exposing the plates to 
ultraviolet light (λ=312 nm). 
 
TRANSMISSION ELECTRON MICROGRAPH 
Transmission electron micrography was used to detect the production and accumu-
lation of polyhydroxybutyrate (PHB) granules in the cytoplasm of E. coli cells. A sin-
gle colony of strain PAD 282 carrying plasmid pPHB3 was incubated overnight in 5 
mL of TB7 containing 100 μg/mL ampicillin. 2 mL of the overnight culture was col-
lected and the cells were pelleted using a table-top centrifuge at 16000 RCF for 1 
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minute at room temperature. The cell pellet was resuspended with 1 mL of fixing 
solution (1.2% glutaraldehyde, 0.45 M cacodylate buffer pH 7.3 and 0.1% ruthenium 
red) and incubated overnight at room temperature. After overnight incubation, the 
cells were pelleted at room temperature using a table-top centrifuge at 16000 RCF 
for 3 minutes, the eppendorf tube was rotated 180° and spun again for 1 min at the 
same RCF. After the final centrifugation, the supernatant was decanted and the cell 
pellet was washed for 10 minutes twice with washing buffer (0.45 M cacodylate 
buffer pH 7.3 and 0.1% ruthenium red). After the second wash, the cell pellet was 
incubated for 1 hour at room temperature in washing buffer containing 4% osmium 
tetroxide, after which they were washed twice again for 10 minutes with washing 
buffer. The cells were then dehydrated by a series of 15-minute ethanol washes at 
room temperature with increasing concentration of ethanol: 25%, 50%, 75%, 90% 
and four 15-minute washes with 100% ethanol, followed by two 10-min washes 
with propylene oxide at room temperature. At the end of the second propylene ox-
ide wash, the pellet was incubated overnight with a 1:1 mixture of resin and propyl-
ene oxide, followed by a 7-8 hour incubation with a 3:1 mixture of resin and propyl-
ene oxide, ending with an overnight incubation in 100% resin. After the last resin 
incubation, the samples were placed in molds, filled with fresh resin and placed in 
the oven overnight, after which the samples were ready to be processed and visual-
ized. 
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WESTERN IMMUNOBLOT ANALYSIS 
For Western Immunoblot analysis, 1.5 ml of cell culture was used. The cells 
were pelleted by centrifugation. Cell lysis was accomplished by one of the following 
methods: sonication, resuspension in 2x SDS buffer (120 mM Tris-Cl [pH 6.8], 4% 
SDS, 0.2% bromophenol blue, 20% glycerol and 10% 2-mercaptoethanol), or Bug-
busterTM (according to manufacturer’s instructions).  The protein samples were re-
solved by electrophoresis on a SDS-PAGE 12% polyacrylamide gel, transferred to 
PVDF or nitrocellulose membrane, and subjected to Western immunoblot analysis. 
Protein detection occurred by incubating the membrane with primary anti-
body in 5% milk solution overnight at 4°C with shaking. Secondary goat anti-rabbit 
(Cell Signaling Technology®) immunoglobulin G antibody at a 1:1000 dilution, or 
goat anti-mouse (Millipore) immunoglobulin G antibody at 1:5000 dilution both 
conjugated to horseradish peroxidase were used for 1 hour at room temperature 
with shaking. For visualization, enhanced chemiluminescence Western immunoblot-
ting reagents (Cell Signaling Technology®) were used, according to the manufactur-
er’s instructions. 
When necessary, membrane stripping was performed with OneMinute® 
Western Blot Stripping Buffer (GM Biosciences), according to the manufacturer’s 
instructions. 
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IMMUNOPRECIPITATION 
For immunoprecipitation, 50 mL buffered TB cultures were collected after 
7.5 hours of incubation at 37°C, pelleted by centrifugation, resuspended in 5 mL TE 
buffer  and lysed by sonication. 1 mL of lysate was used for immunoprecipitation of 
RNAP with RNAP β mouse monoclonal antibodies (NeoClone Biotechnology) or im-
munoprecipitation of CpxR with MBP-CpxR rabbit polyclonal antibody (111) and 
rotated overnight at 4°C. Protein G-Sepharose® (Sigma) was used to ‘pull down’ an-
tibodies from cell lysate. The precipitated beads were washed three times with TE 
buffer and once with wash buffer containing 100 mM NaCl and 50 mM Tris-HCl at 
pH 7.2. Loading buffer was added directly to the beads and samples were heated to 
95°C for 5 minutes. Samples were separated by SDS-PAGE and stained with NOVEX® 
Colloidal Blue Stain (Invitrogen), according to the manufacturer’s instructions. 
 
ORBITRAP-MASS SPECTROMETRY AND PROTEIN IDENTIFICATION 
The α, β and β’ bands were excised and subjected to tryptic digestion, as de-
scribed previously (20). Tryptic peptides were separated and measured online by 
ESI-mass spectrometry using a nanoACQUITY UPLC™ system (Waters, Milford, MA) 
coupled to an LTQ Orbitrap™ XL mass spectrometer (Thermo Fisher Scientific, Wal-
tham, MA). A trap column (Symmetry® C18, 5 µm, 180µm inner diameter x 20mm, 
Waters) was used for desalting. Elution was performed onto an analytical column 
(BEH130 C18, 1,7 µm, 100 µm inner diameter x 100mm, Waters) by a binary gradi-
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ent of buffers A (0.1% (v/v) acetic acid) and B (99.9 % (v/v) acetonitrile, 0.1% (v/v) 
acetic acid) over a period of 80 min with a flow rate of 400 nl/ min. The Orbitrap XL 
was operated in data-dependent MS/MS mode using the lockmass option for real 
time recalibration. 
Proteins were identified by searching all MS/MS spectra in “dta” format 
against  an E. coli  database (extracted from the Uniprot-KB database: 
http://www.uniprot.org/uniprot/?query=Escherichia+coli+K12&sort=score) using 
Sorcerer™-SEQUEST® (Sequest v. 2.7 rev. 11, Thermo Electron including Scaf-
fold_3_00_05, Proteome Software Inc., Portland, OR). The Sequest search was car-
ried out considering the following parameters: a parent ion mass tolerance - 10 
ppm, fragment ion mass tolerances of 1.00 Da. Up to two tryptic miscleavages were 
allowed. Methionine oxidation (+15.99492 Da), cysteine carbamidomethylation 
(+57.021465 Da) and lysine acetylation (+42.010571 Da) were set as variable modi-
fications. Proteins were identified by at least two peptides applying a stringent SE-
QUEST filter. Sequest identifications required at least ΔCn scores of greater than 
0.10 and XCorr scores of greater than 1.9, 2.2, 3.3 and 3.8 for singly, doubly, triply 
and quadruply charged peptides. Acetylated peptides that passed these filter criteria 
were examined manually and accepted only when b- or y- ions confirmed the acety-
lation site. 
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CpxR EXPRESSION AND PURIFICATION 
CpxR expression was carried out in BL21 (DE3) cells transformed with 
pBPL001. An overnight culture of the transformants was used to inoculate 1 L of LB 
at an initial OD600 of 0.05. The culture was incubated at 37°C with shaking at 250 
RPM. Once the OD600 reached 0.6, 250 μM IPTG was added to the culture to induce 
CpxR expression. After three hours of induction, the cell pellet was collected by cen-
trifugation at 10000 RCF for 10 minutes at 4°C and stored at -20°C overnight. 
Cell lysis began by resuspending the pellet with 10 mL BugBuster (Novagen®) and 
10 μL lysonaseTM (Novagen®). The resuspended cell pellet was incubated for 30 
minutes at room temperature with gentile shaking. Following this room tempera-
ture incubation, 30 mL of pH 8.0 resuspension buffer (50 mM Na2HPO4, 1.4 M NaCl, 
20 mM imidazole, 0.1% Tween 20, 5% ethanol and 15 mM -mercaptoethanol) was 
added to the resuspended pellet. The cell debris was pelleted by centrifugation at 
15000 RCF, at 4°C for 30 minutes. The supernatant was loaded onto a 500 μL TAL-
ON® Metal Affinity Resin (Clontech) column, washed with 10 mL wash buffer (50 
mM Na2HPO4, 0.3 M NaCl, 30 mM imidazole, 0.1% Tween 20 and 0.5% ethanol) 
buffered at pH 8.0. CpxR elution was performed in a stepwise manner by flowing 
500 μL of wash buffer with increasing imidazole concentration from 35 mM to 85 
mM in 5 mM increments. Fractions 6-11 were collected, combined and dialysed 
overnight at 4°C into storage buffer (10 mM Tris-HCl pH 8.0, 100 mM KCl, 50% glyc-
erol, 10 mM MgCl2, 0.1 mM EDTA and 1 mM DTT). The dialysed protein was divided 
into aliquots, which were stored at -80°C for future use. 
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IN VITRO PHOSPHORYLATION 
In vitro phosphorylation of CpxR was carried out by incubating lithium po-
tassium AcP (Sigma Aldrich) with purified His-tagged CpxR at 30°C for 15 minutes 
in buffer containing 40 mM Tris-HCl pH 8.0, 10 mM MgCl2, 40 mM KCl and 1 mM 
DTT. The reaction was quenched by the addition of SDS loading buffer. 
 
DETECTION OF PHOSPHORYLATED CpxR 
Whether from cell lysates or from in vitro phosphorylation, phosphorylated 
CpxR was detected by first separating phosphorylated from nonphosphorylated 
CpxR using Zinc (II) Phos-TagTM SDS- PAGE [10% acrylamide (29:1), 350 mM Tris 
pH 6.8, 0.1% SDS, 75 µM Phos-TagTM (NARD Institute LTD) and 150 µM Zn(NO3)2] 
(Boulanger-Castaing, A., and Hinton, D. M., personal communication). Purified pro-
tein was detected by staining the gel with SimplyBlueTM (Invitrogen), whereas pro-
tein from cell lysate was visualised by Western immunoblot with anti-His6 antibody 
(CellSignaling). Cell lysis for Phos-TagTM analysis was executed at 4°C with 2X-SDS 
loading buffer. Prior to transfer of the protein onto the membrane, the gel was incu-
bated at room temperature with gentle shaking for 15 minutes in Towbin buffer (50 
mM tris and 40 mM glycine) containing 1 mM EDTA to chelate the zinc and then for 
another 15 minutes in only Towbin buffer. 
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IN VITRO ACETYLATION 
In vitro acetylation of RNA polymerase was conducted with two distinct ace-
tyl donors: acetyl-CoA (AcCoA) and acetylphosphate (AcP). 
AcCoA - In vitro acetylation of purified RNA polymerase with AcCoA and purified 
His6-YfiQ was carried out by mixing 1.5 µM YfiQ, 3.5 µM RNAP and 0.05 mM [14C]- 
AcCoA in an in vitro acetylation buffer (50 mM Tris-HCl pH 8.0, 10% glycerol, 10 mM 
sodium butyrate, 1 mM DTT) to a final volume of 20 µL. The reaction was incubated 
for 1 hour at 37°C and stopped by the addition of NuPAGE 4X SDS loading buffer. 
For visualization, the samples were heated at 95°C for 2 minutes, and re-
solved using a 12% acrylamide SDS-PAGE gel. After sample separation, the gel was 
dried for 2 hours using a gel dryer. Images were obtained by exposing a storage 
phospho screen to the dry gel overnight. The screen was read using a Typhon phos-
phoimager. 
AcP - In vitro acetylation of purified RNA polymerase with AcP was carried out by 
mixing 3.5 µM RNAP with AcP at concentrations ranging from 0-40 mM in in vitro 
transcription buffer (40 mM Tris-HCl pH 8.0, 10mM MgCl2, 50 mM KCl, and 1mM 
DTT) and incubated for 1 hour at 30°C. After 1 hour, the reaction was stopped by the 
addition of standard 2X SDS loading buffer. Protein acetylation by AcP was detected 
by Western immunoblot analysis using an antibody against acetylated lysine 
(CellSignaling) at a ratio of 1:500. 
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IN VITRO TRANSCRIPTION 
In vitro transcription of cpxP and all other promoters described in this disser-
tation was executed by multiple round transcriptions. The final volume of the in 
vitro transcription reaction was 25 µL and contained 1x in vitro transcription buffer 
(40 mM Tris-HCl pH 8.0, 10mM MgCl2, 50 mM KCl, 1mM DTT and 25 ng BSA), 1X 
NTP mixture (200 µM ATP, CTP and GTP, and 10 µM UTP), 2 µCi alpha [32P]UTP, 50 
ng p770-cpxP plasmid, purified His6-CpxR at concentrations ranging from 0.0-0.8 
µM, AcP at concentrations ranging from 0 – 40 mM, and 10 nM of purified RNA pol-
ymerase-containing sigma 70 (Eσ70). When multiple reactions were performed per 
experiment, they were started at 30 second intervals by the addition of Eσ70 and in-
cubated at 30°C for 15 minutes. After incubation, the reactions were stopped (also 
at 30-second intervals) by the addition of 25 µl of 2x stop solution (7 M Urea, 10 mM 
EDTA, 1% SDS, 2X TBE and 0.05% bromophenol blue). Immediately following the 
addition of the stop solution, the reactions were transferred onto ice. 
The transcript fragments were separated using a denaturing acrylamide gel 
containing (6% acrylamide [19:1 acryl.:bis.], 7 M urea and 1x TBE). Polymerization 
was initiated by the addition of 0.01% of freshly made 10% APS solution and 
0.001% TEMED and allowed to polymerize for 1 hour and 30 minutes undisturbed 
at room temperature. 
23 µL of the in vitro transcription/stop solution reaction was loaded into the 
gel wells. The samples were allowed to run at approximately 200V for approximate-
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ly 1.5-2 hours until the dye reached a position approximately 3 inches from the bot-
tom of the gel, which keeps the unincorporated radioactivity on the gel and makes 
cleaning up the radioactive waste much easier.  1x TBE was used as the running 
buffer. Prior to phosphor imaging, the gels were dried using a gel drier for 2 hours. 
Images were obtained by exposing a storage phosphor screen to the dry gel over-
night. The screen was read using a Typhon phosphoimager. The unused in vitro 
transcription reaction was stored at -20°C. 
 
RNA POLYMERASE EXPRESSION AND PURIFICATION 
RNAP expression - A single colony of BL21 (DE3) cells carrying plasmid 
pIA900 was inoculated into 50 mL of LB containing 100 μg/mL ampicillin and incu-
bated overnight at 37°C with aeration, rotating at 250 RPM.  This overnight culture 
was used the following day to inoculate 1 L of LB containing 100 µg/mL ampicillin 
in a 2 L baffled flask, bringing the OD600 to 0.05.  The culture was incubated at 37°C 
with aeration, rotating at 250 RPM until the culture OD600 reached 0.6, at which 
point 1 mM IPTG was added to induce RNA polymerase expression. RNAP expres-
sion was allowed to continue for approximately 6 hours under the same conditions 
before the culture was split into two 500 mL aliquots and the cells were pelleted by 
centrifugation at 10000 RCF for 10 minutes at 4°C. After centrifugation the superna-
tant was decanted and the cell pellets were placed at -20°C overnight or until cell 
lysis. 
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Protein extraction - For protein extraction, the cell pellets were allowed to 
thaw on ice. After thawing, 5 mL BugBuster (Novagen®) and 5 μL lysonaseTM (No-
vagen®) was used to resuspend the cell pellets. After resuspension, the mixture 
were transferred to OakRidge tubes and incubated at room temperature for 30 
minutes with gentle shaking. After incubation, 15 ml of RNAP resuspension buffer 
pH 8.0 was added (50 mM Na2HPO4, 1.4 M NaCl, 20 mM imidazole, 0.1% Tween 20, 
5% ethanol and 15 mM β-mercaptoethanol). Cell debris was pelleted at 16000 RCF 
for 30 min at 4°C, after which the supernatant was collected for protein purification. 
RNA Polymerase Purification – Purification of RNAP was conducted by pass-
ing the supernatant through a 1 mL cobalt resin bed that had been previously 
washed twice with 10 mL of water and equilibrated with 10 mL resuspension buff-
er. After the cell lysate was passed through the column, the column was washed 
with 10 mL wash buffer at pH 8.0 (50 mM Na2HPO4, 0.3 M NaCl, 30 mM imidazole, 
0.1% Tween 20 and 5% ethanol). Protein elution was achieved by passing 3 mL of 
wash buffer containing 300 mM imidazole through the column. The eluted solution 
was collected and diluted into 3 mL TGED (0.01 M Tris-HCl pH 8.0, 5% glycerol, 0.1 
mM EDTA, 0.1 M NaCl and 2 mM DTT). The diluted eluate was loaded onto 400 µL of 
heparin resin previously washed twice with 10 mL of water and equilibrated with 
TGED. The flow-through was collected and passed over the column a second time, 
after which the column was washed with 6 ml TGED containing 0.2 M NaCl, and 
RNAP was eluted from the column with 3 mL of TGED containing 0.6 M NaCl. The 
flow-through was transferred into a dialysis cassette and placed into 1 L dialy-
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sis/storage buffer (10 mM Tris-HCl pH 8.0, 100 mM KCl, 50% glycerol, 10 mM 
MgCl2, 0.1 mM EDTA and 1 mM DTT) overnight at 4°C with gentle stirring. After di-
alysis the samples were divided ino aliquots and stored at -80°C for future use. 
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CHAPTER THREE 
RESULTS 
ACETYLPHOSPHATE AS A PHOSPHORYL DONOR 
In this chapter, I will address the hypothesis that AcP can function as a phos-
phoryl donor to RRs in vivo. Using a combination of genetic and biochemical ap-
proaches, I will specifically test the hypothesis that the RR CpxR can be phosphory-
lated by AcP in vivo, and that this phosphorylation event affects transcriptional 
regulation of the E. coli stress-responsive gene cpxP. 
 
DOES cpxP TRANSCRIPTION RESPOND TO GENETIC MANIPULATIONS  
PREDICTED TO AFFECT INTRACELLULAR LEVELS OF AcP? 
Linkage between AcP and several 2CST pathways has been proposed previ-
ously [reviewed in (144, 145)]. Only a few studies, however, have provided strong 
genetic evidence for this linkage in vivo (38, 119). As part of my efforts to map the 
impact of AcP on transcriptional regulation of E. coli promoters, I re-explored the 
relationship between AcP and the transcriptional regulation of cpxP, via genetic ma-
nipulation of the Pta-AckA pathway and the 2CST pathway CpxAR. 
cpxP is the most sensitive of the more than 100 E. coli genes predicted to be 
regulated by phosphorylation of CpxR (29, 30).  cpxP transcription requires the RR 
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CpxR and it is thought to be almost exclusively dependent on it (23), making cpxP 
transcription a good readout of CpxR phosphorylation. 
Although CpxR is thought to be absolutely required for cpxP transcription, 
the cognate SK CpxA is not. cpxP transcription can still be induced in cpxA mutants 
when glucose is supplemented to rich medium (23), an observation that has con-
tributed to the hypothesis that, in the absence of CpxA, CpxR could be phosphory-
lated by AcP (23). 
Besides responding to the addition of glucose to rich medium, the CpxAR 
pathway has been shown to integrate and respond to multiple environmental cues, 
including entry into stationary phase, alkaline pH, attachment to hydrophobic sur-
faces, the presence of copper in the extracellular environment and the accumulation 
of pilus subunits in the periplasm [reviewed in (137)]. Therefore, before I could de-
termine if AcP influenced cpxP transcription, I first characterized cpxP transcription 
both in the presence and absence of glucose and determined whether the previously 
reported response to glucose could be the summation of multiple signals or if it was 
due solely to the presence of AcP. 
To assess cpxP transcription, I measured β-galactosidase activity from 
ϕ(PcpxP-lacZ) (23), which is carried  by the hybrid bacteriophage λRS88 and pre-
sent as a monolysogen in the λattB site of the chromosome of WT cells (strain 
PAD282) and its isogenic mutants ackA (strain AJW2790), ackA pta (strain 
AJW2791), cpxA (strain PAD348), and cpxR1 (strain PAD292) (30) (Table 1). The 
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cpxR1 allele has a polar effect on the downstream gene cpxA; thus, the resultant 
strain lacks both CpxR and CpxA (24). 
I grew these strains in TB at 37°C, harvested cells at regular intervals, and 
compared their growth characteristics and β-galactosidase activities. Mutants lack-
ing CpxA or CpxR exhibited growth characteristics indistinguishable from those of 
their WT parent. In contrast, mutants lacking AckA or both AckA and Pta, as report-
ed previously (148), grew more slowly but to a similar density (Fig. 6A). Because of 
the difference in the growth rate, all data obtained subsequently were plotted ver-
sus OD600, although for some experiments, only the last time point is shown. 
WT cells exhibited two peaks of cpxP activity; the first and smaller peak oc-
curred in mid-exponential phase (OD600, 0.5) and reached about 13,000 Miller 
units, while the second and larger peak corresponded with entry into stationary 
phase (OD600, 1.0) and reached about 46,000 Miller units (Fig. 6B). Both behaviors 
depended upon CpxA and CpxR, as both cpxA and cpxR mutants exhibited low activi-
ty throughout growth. Intriguingly, ackA and ackA pta mutants had a hybrid profile; 
they exhibited little activity during exponential growth but displayed substantial 
activity during entry into stationary phase. The existence of two activity peaks led 
me to speculate whether there were two distinct stimuli, one associated with expo-
nential growth and one associated with entry into stationary phase. To be consistent 
with previously published data, I focused on the increase in cpxP transcription as 
the cultures entered stationary phase. 
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STATIONARY-PHASE BEHAVIOR IS A CpxA-DEPENDENT  
RESPONSE TO ALKALINE pH. 
cpxP transcription has been reported to become activated in response to 
both elevated pH (23, 95) and entry into stationary phase (28, 30). Because TB is 
composed primarily of amino acids and because consumption of amino acids leads 
to the production of ammonia (104, 148), I expected that the culture pH would rise 
as the cells consumed amino acids and entered stationary phase and that the in-
creased pH could lead to increased cpxP transcription. To test this hypothesis, I 
monitored the pH of the culture medium throughout growth and found that all five 
strains (WT, cpxA, cpxR, ackA and ackA pta) behaved almost identically (Fig. 6C). 
Each strain dramatically alkalinized its environment during the transition from ex-
ponential to stationary phase. In each case, the maximum pH reached by the culture 
was about 8.4. During mid-exponential growth, the cpxA and cpxR mutants and their 
WT parent slightly acidified their environments before alkalinizing them. The ackA 
and ackA pta mutants, in contrast, did not do this. This behavior can be attributed to 
the substantially reduced ability of mutants that lack a functional Pta-AckA pathway 
to generate and excrete acetate (104, 148). 
Since the increase in pH was concomitant with entry into stationary phase, I 
performed two different experiments to distinguish between these two potentially 
distinct stimuli. First, I grew cells at 37°C in TB buffered at pH7 or TB buffered at 
pH8, harvested cells at regular intervals, and monitored their growth and cpxP activ-
ity. When grown at pH 8.0, WT cells exhibited about five times more promoter activ-
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ity than they exhibited when they were grown at pH 7.0. In contrast, cpxA mutant 
exhibited weak promoter activity regardless of the pH (Fig. 7B). Since both types of 
cells grew more than twice as slowly at pH 8.0 as they did at pH 7.0 (Fig. 7A), it is 
possible that the higher activity at pH 8.0 could have been due to the lower growth 
rate instead of the higher pH. To differentiate between these two possibilities, I 
grew WT cells and cpxA mutants at 37°C in either unbuffered TB or TB buffered at 
pH7 (TB7). I harvested cells at regular intervals, and monitored their growth and 
cpxP activity (Fig. 8). WT cells exhibited high levels of cpxP activity in TB but not in 
TB7. In contrast, buffering had no significant effect on the cpxP activity exhibited by 
cpxA mutants. These results support the conclusion that pH is the primary stimulus 
behind the cpxP activity exhibited by WT cells as they enter stationary phase and, by 
extension, the isogenic ackA and ackA pta mutants. Furthermore, these data lend 
credence to the reports that the pH response requires CpxA (23, 95). 
 
cpxP RESPONSE TO EXCESS CARBON REQUIRES THE Pta-AckA PATHWAY 
It has been reported that exposure to exogenous glucose induces a CpxR-
dependent cpxP transcription that depends on AcP (23, 24). However, the medium 
used to derive this conclusion was not buffered. Since I found that pH has a signifi-
cant effect on cpxP transcription, I revisited this conclusion. 
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Exposure to pyruvate (a three-carbon glycolytic intermediate) results in 
greater accumulation of intracellular AcP than exposure to glucose (a six-carbon 
compound) (64, 72). Thus, to investigate the effect of AcP on cpxP transcription, I 
began by exposing cells to pyruvate. To be able to compare the cpxP responses to 
the two compounds, I standardized the concentration to the total number of car-
bons. Since 0.4% was the glucose concentration used previously (23, 24), I conduct-
ed my experiments with 0.8% sodium pyruvate. I grew WT cells and cpxA mutants 
at 37°C in pyruvate-supplemented TB7, harvested cells at regular intervals, and 
monitored their growth (data not shown) and cpxP activity (Fig. 8). Although WT 
cells responded to the presence of pyruvate, the total activity was less than one-half 
that of WT cells grown in unbuffered pyruvate-supplemented TB. In contrast, cpxA 
mutants responded strongly when they were exposed to pyruvate regardless of 
buffering. As reported previously for glucose (23), the cpxA mutant response to py-
ruvate was stronger than the response of its WT parent. Thus, in this context, CpxA 
inhibited the response to pyruvate, a behavior consistent with its reputed phospho-
CpxR phosphatase activity (36, 111). Furthermore, my data corroborated previous 
observations that seem to support the proposition that CpxR can become activated 
in a CpxA-independent manner. 
To determine if the CpxA-independent response to pyruvate requires the 
Pta-AckA pathway, I performed an epistasis analysis. I combined mutations in the 
Pta-AckA pathway with mutations in the CpxAR signaling pathway and compared 
the behavior of the cells in the presence and absence of pyruvate (Fig. 9A). WT cells 
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responded moderately (about threefold) to pyruvate and only upon entry into sta-
tionary phase. In contrast, the cpxA mutant cells responded early and dramatically; 
their cpxP activity increased about nine fold from exponential growth to entry into 
stationary phase. Thus, the inhibitory effect of CpxA appears to maintain low cpxP 
activity throughout exponential growth and to limit the response upon entry into 
stationary phase, at least in medium buffered at pH 7.0. Conversely, cells lacking 
CpxA and AckA or CpxA, AckA and Pta did not respond to pyruvate (Fig. 9 B and C). 
This supports the hypothesis that the response to pyruvate requires the Pta-AckA 
pathway. 
 
CPXA-INDEPENDENT cpxP TRANSCRIPTION REQUIRES PTA-ACKA   
BUT DOES NOT CORRELATE WITH PREDICTED INTRACELLULAR ACP LEVELS 
To activate cpxP activity in the absence of CpxA, CpxR must have an alterna-
tive source of phosphoryl groups. Since the pyruvate response requires the Pta-
AckA pathway, a prime candidate is the pathway intermediate, AcP, which has been 
shown to act through at least one other 2CST RR (RcsB) to influence genes involved 
in flagellation and encapsulation (38). Furthermore, CpxR can use AcP as a phos-
phoryl donor in vitro (101, 111), and AcP has been proposed to be responsible for 
the CpxA-independent glucose response (6, 23, 24). To be consistent with previous-
ly published data, from this point on, I used glucose to induce cpxP transcription and 
to test the hypothesis that AcP is responsible for the CpxA-independent, glucose-
induced cpxP transcription. 
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If AcP is the phosphoryl donor for CpxA-independent activity, then one 
would predict that the cpxA ackA double mutant, which accumulates AcP, would ex-
hibit more activity than the cpxA mutant, while the cpxA ackA pta triple mutant, 
which cannot synthesize AcP, would exhibit less. While the latter is true, the former 
is not (Fig. 10A). As previously reported, and consistent with the role of CpxA as a 
phosphatase, cpxA mutants responded to glucose more strongly than its WT parent. 
Although the CpxA-independent response depended on the presence of the Pta-
AckA pathway, cells that lacked CpxA and AckA exhibited a response that was weak-
er than that seen by the cpxA mutant and not the predicted stronger response. 
Therefore, I concluded that the response to glucose requires an intact Pta-AckA 
pathway. The lack of response by the pta ackA mutant argues that the Pta-AckA 
pathway is required and the response by the ackA mutant suggests that the re-
sponse involves AcP, but the weakness of the response suggests that something else 
is involved. 
To test the hypothesis that AcP does activate cpxP transcription, I took ad-
vantage of the fact pta mutants retain a functional AckA and that the Pta-AckA 
pathway is reversible.  Thus, since AckA converts acetate to AcP, I could set AcP lev-
els by controlling the amount of acetate added to the medium (64), and create a 
condition in which we could have AcP at a concentration that is predicted to be 
higher than WT, and yet, maintain a functional AckA enzyme. 
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To obtain that condition, I grew strains lacking CpxA and either AckA or Pta 
or both in TB7 or TB7 supplemented with 15 mM potassium acetate. Both the cpxA 
and cpxA pta mutants responded by exhibiting statistically significant cpxP activity 
when compare to cells grown in the absence of acetate, while the cpxA ackA and 
cpxA ackA pta mutants did not (Fig. 10B). Thus, I concluded that AcP can activate 
cpxP transcription. If so, then why is the response weaker when compared to cells 
that possess an intact Pta-AckA pathway? One possibility is that an inhibitor exists 
under conditions that presumably induce very high AcP concentration. To test this 
idea, I exposed cpxA mutants (which possess intact Pta-AckA pathway) to increasing 
concentrations of glucose. Consistent with the idea that an inhibitor of cpxP tran-
scription accumulates under conditions that are expected to produce large AcP con-
centrations, I detected an increase in cpxP when cells were exposed to glucose con-
centrations up to 0.4%, but a progressive decrease in the presence of larger 
amounts, e.g. 4.0% (Fig. 11). 
On the basis of these results, I conclude that AcP contributes to cpxP tran-
scription, perhaps via the transfer of a phosphoryl group from AcP to CpxR, as such 
a transfer has been shown to occur in vitro (85, 101). Since cpxP transcription fails 
to strictly correlate with expected intracellular levels of AcP, it is possible that AcP is 
not the sole contributor to CpxA-independent, glucose-induced cpxP transcription. 
In this dissertation, I will first ask if a transfer of phosphoryl groups occurs between 
AcP and CpxR and later ask whether factors other than CpxR phosphorylation con-
tribute to the CpxA-independent, glucose-induced transcription of cpxP. 
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GLUCOSE-INDUCED cpxP TRANSCRIPTION REQUIRES ASP-51, 
 THE CONSERVED PHOSPHORYL ACCEPTOR RESIDUE OF CPXR 
 The knowledge that glucose-induced cpxP transcription is affected by AcP, 
that it does not require the sensor kinase CpxA, but that it requires the cognate re-
sponse regulator CpxR (149), led me to re-investigate the role of CpxR phosphoryla-
tion. To address this question, I attempted to complement the cpxR1 mutant allele in 
a strain that carries the transcriptional fusion Φ(PcpxP’-lacZ) (strain PAD 292; Ta-
ble 1). Complementation was attempted by transformation with either plasmid-
borne WT cpxR (pCA24n-cpxR; Table 1) or plasmid-borne cpxRD51A (pCA24n-
cpxRD51A; Table 1). The latter encodes a mutant protein that lacks the conserved 
aspartyl residue that serves as the phospho-acceptor site. Both alleles were ex-
pressed from an IPTG-inducible promoter. I grew the resultant transformants in TB 
with or without the presence of 0.4% glucose and measured -galactosidase activity 
as a reporter of cpxP promoter function. The transformants that expressed WT CpxR 
responded to glucose. In contrast, the transformants that expressed CpxRD51A did 
not (Fig. 12, left). Since Western immunoblot analysis indicated that the steady 
state levels of the WT and mutant forms of CpxR proteins were similar (Fig. 12, in-
set), the lack of cpxP transcription by cells that express the mutant protein cannot 
be explained by a difference in protein expression levels.  Instead, this lack of re-
sponse likely resulted from the mutant protein’s inability to become phosphorylated 
(Fig. 13B). I therefore conclude that the response to glucose by cpxP requires AsP-
51 and propose that this response requires phosphorylation of CpxR. 
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THE RESPONSE TO GLUCOSE REQUIRES ACETYL PHOSPHATE 
 The knowledge that CpxA-independent, glucose-induced cpxP transcription 
seems to be, at least in part, dependent on AcP and seems to require phospho-CpxR 
led me to investigate if the weak response to glucose by the ackA mutant required 
CpxR phosphorylation, perhaps an indicator that AcP could indeed function as a do-
nor of phosphoryl groups to CpxR. 
 If AcP can function as a phosphoryl donor to CpxR, then the cpxR1 ackA dou-
ble mutant (strain AJW3827; Table 1), which accumulates AcP (72, 146), should re-
spond to the addition of glucose in a Asp-51-dependent manner. In contrast, I pre-
dicted that the cpxR1 pta ackA triple mutant (strain AJW3875; Table 1), which can-
not synthesize AcP (72, 146), would not respond to exogenous glucose regardless of 
the status of Asp-51. Indeed, the cpxR1 ackA double mutant responded to glucose in 
an Asp-51-dependent manner, while the cpxR1 pta ackA triple mutant did not re-
spond to glucose (Fig. 12A, middle and right respectively). Thus, in the absence of 
CpxA and in the presence of glucose, cpxP transcription requires both Asp-51 and 
AcP. 
 
IN VIVO PHOSPHO-CpxR LEVELS CORRELATE WITH AcP  
BUT NOT WITH cpxP TRANSCRIPTION 
 The simplest explanation for the requirement of both AcP and Asp-51 is that 
the CpxA-independent, glucose-induced cpxP transcription requires an AcP-
dependent phosphorylation of CpxR. Despite this requirement for AcP, the AcP-
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accumulating ackA mutant fails to promote the predicted proportional increase in 
cpxP transcription (See Figures 10A, B and 12). To understand this paradoxical 
behavior, we assessed whether in vivo levels of phospho-CpxR correlate with those 
of AcP in strains WT or mutant for the Pta-AckA pathway. 
 To monitor phospho-CpxR, I took advantage of a previously reported method 
used for the detection of phosphorylated proteins (69, 70), including bacterial re-
sponse regulators (5, 85). This method uses a dinuclear metal complex (i.e. 1,3-bis 
[bis (pyridin-2-ylmethyl) amino] propan-2-olato dizinc [II]) that has affinity for 
phosphomonoester dianions, such as the aspartyl phosphate of response regulators. 
When included in an SDS-PAGE gel, this phosphate-binding tag (Phos-TagTM) slows 
the migration of the phosphorylated protein, allowing it to be distinguished from 
the non-phosphorylated protein by mobility shift. 
 To verify the report that AcP can function in vitro as a phosphoryl donor to 
CpxR (101) and to optimize the assay, I incubated purified His6-CpxR with AcP, re-
solved the proteins by Phos-TagTM SDS-PAGE and stained the gel with SimplyBlueTM 
(Invitrogen). I detected an AcP-dependent shift in CpxR migration that disappeared 
when the sample was exposed to 95°C for 15 minutes, a condition that induces hy-
drolysis of phosphorylated aspartyl residues (Fig. 13A). 
 To test the hypothesis that glucose induces cpxP transcription by increasing 
phospho-CpxR concentration, I assessed the cpxR1 mutant (strain PAD292) trans-
formed with plasmids that expressed either His6-CpxR or His6-CpxR D51A. I grew 
the transformants in the absence or presence of 0.4% glucose, harvested cells as the 
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cultures entered stationary phase, separated the cell lysates by Phos-TagTM SDS-
PAGE and performed a Western immunoblot analysis with anti-His6 antibody. Con-
sistent with the idea that glucose-induced cpxP transcription requires phospho-
CpxR, I detected a glucose- and Asp-51-dependent shift in CpxR that was sensitive to 
heat (Fig. 13B). 
 To test the role of AcP, I performed a similar experiment on cpxR1 ackA 
(strain AJW3827, Table 1) and cpxR1 pta ackA (strain AJW3875, Table 1) mutants 
transformed with the His6-CpxR expression plasmid. Consistent with the hypothesis 
that AcP mediates CpxR phosphorylation, the shifted band was absent in the cells 
that cannot synthesize AcP (cpxR1 pta ackA) but present in the cells that accumulate 
AcP (cpxR1 ackA) (Fig. 13C). 
 To facilitate detection of shifted phospho-CpxR, the aforementioned Phos-
TagTM experiments were performed with cells that overexpressed His6-CpxR. Be-
cause I was aware that overexpression of tagged proteins often causes artifacts, I 
performed a similar experiment with WT and cpxA mutant cells that expressed WT 
CpxR from the native locus. In response to glucose, the phosphorylated fraction of 
native CpxR increased substantially, regardless of the status of CpxA (Fig. 13D). 
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CONCLUSION 
AcP has been proposed to play a role in transcription regulation by serving as 
a phosphoryl group donor to several RRs. In this chapter, I tested this hypothesis 
using the CpxAR system, which had been proposed previously to be influenced by an 
AcP-dependent phosphorylation of the RR CpxR. 
My results demonstrate that the addition of glucose, pyruvate and acetate to 
TB7 can induce cpxP transcription even in the absence of the cognate sensory pro-
tein CpxA. Genetic manipulations of the Pta-AckA pathway and of the CpxAR 2CST 
demonstrated that glucose-induced (and to some degree pyruvate-induced) cpxP 
transcription requires the Pta-AckA pathway, CpxR and its phosphorylation site, 
Asp-51. The simplest explanation to these results is that, in the absence of CpxA and 
in the presence of glucose, and likely other carbon sources, AcP can function as the 
phosphoryl donor to CpxR, and that this phosphoryl transfer leads to transcription 
activation of cpxP. The conclusions derived from my genetic experiments were sup-
ported by biochemical data that demonstrate that in vivo phosphorylation of CpxR 
requires glucose, AcP and the phosphorylation site, Asp-51. This was the first time 
that biochemical evidence demonstrated that a RR is phosphorylated in vivo in an 
AcP-dependent manner and showed that the AcP-dependent phosphorylation site is 
the same as the one phosphorylated by the cognate sensor kinase-dependent mech-
anism. While these results make a straightforward case for the transfer of phos-
phoryl group from AcP to CpxR, the weak response to glucose by ackA mutants, de-
67 
 
 
 
spite the presence of phosphorylated CpxR, suggests that regulation of cpxP tran-
scription involves more than just CpxR phosphorylation. 
In the following chapter, I will address the hypothesis that regulatory mech-
anisms, other than CpxR phosphorylation, are involved in the CpxA-independent, 
glucose-induced cpxP transcription.
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CHAPTER FOUR 
RESULTS 
ACETYLATION AND TRANSCRIPTIONAL REGULATION 
In the previous chapter, I provided evidence that supports the hypothesis 
that, upon the addition of 0.4% glucose to TB, AcP phosphorylates CpxR in vivo and 
that this phosphorylation event impacts cpxP transcription. However, cpxP tran-
scription does not fully correlate with the predicted intracellular concentration of 
AcP (64). While I did find that pta ackA double mutants, which do not synthesize 
AcP, failed to induce cpxP transcription, ackA mutants (which are predicted to ac-
cumulate more AcP than WT) exhibited cpxP transcription below WT levels, even 
though CpxR was found to be phosphorylated under the same conditions.  This 
somewhat paradoxical behavior led me to hypothesize that additional regulatory 
mechanism(s) might modulate the CpxA-independent, glucose-induced and AcP-
dependent cpxP transcription. 
Through a series of genetic and biochemical approaches I investigated 
whether, in addition to CpxR phosphorylation, other regulatory mechanism could 
regulate cpxP transcription. The data that I will present here implicate protein 
acetylation in a sophisticated regulatory mechanism that seems to modulate AcP-
dependent cpxP transcription. 
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CATABOLITE REPRESSION 
 In E. coli and many other bacteria, glucose has a profound impact on central 
metabolism, affecting, among other things, the concentration of cyclic-AMP.  Cyclic-
AMP is an important transcriptional regulator that modulates the activity of CRP, 
the master regulator of E. coli central metabolism. By binding to CRP, cyclic-AMP in-
duces a conformational change that allows CRP to interact with many promoter re-
gions and to regulate their activity. Glucose, however, leads to a decrease in total cy-
clic-AMP concentration, preventing CRP from binding DNA [reviewed in (144)]. Alt-
hough there is no evidence that this event (known as catabolite repression) could 
affect cpxP transcription via a direct interaction with the cpxP promoter region, 
there was no evidence to rule out an indirect effect. 
 To test whether catabolite repression could influence cpxP transcription, I 
exposed cpxA mutants (Strain PAD348 Table 1) to a non-catabolite-repressing car-
bon source (acetate) and to two catabolite-repressing carbon sources (glucose and 
pyruvate), measured β-galactosidase activity and compared the cpxP response to 
each of these carbon sources (Fig. 14). Since glucose, pyruvate and acetate induced 
similar responses, it is unlikely that catabolite repression plays a substantive role in 
regulating cpxP transcription. Therefore, I explored other effects that exposure to 
glucose might exert on E. coli physiology. 
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GLUCOSE AND AcP AFFECT GLOBAL PROTEIN ACETYLATION 
 Besides lowering cyclic-AMP levels, glucose rapidly increases the AcCoA con-
centration in E. coli (21) and, recently, it has been shown to promote protein acety-
lation in S. enterica (139). S. enterica, however, is not the only bacterial species 
where protein acetylation occurs; global proteomic studies using mass spectrome-
try analysis have demonstrated that protein acetylation is common also in E. coli 
and B. subtilis (68). The studies in E. coli identified acetylated proteins that are part 
of many physiological processes. Of great interest to me was evidence that some of 
the RNA polymerase subunits (α, β and β’) could be acetylated. Therefore, I consid-
ered the possibility that, in addition to protein phosphorylation, an acetylation event 
could influence cpxP transcription. 
 To test this hypothesis, I first asked whether, similarly to S. enterica, global 
protein acetylation in E. coli could be affected by the addition of glucose to the 
growth medium. To that end, I used a cocktail of two polyclonal anti-acetyllysine an-
tibodies to perform Western immunoblot analysis on whole cell lysates from cpxA 
mutant cells grown either in TB7 supplemented with 0.4% glucose or not (Fig 15). 
As reported for S. enterica (139), the presence of glucose resulted in a general in-
crease in the acetylome, as detected by the increase in number and/or intensity of 
acetylated bands. Subsequently, these results were verified and extended by Bozena 
Zemaitatis (a Research Specialist in our laboratory), who optimized the anti-
acetyllysine Western immunoblot analysis, and quantified by our collaborators Birgit 
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Schilling and Bradford Gibson (Buck Institute for Aging, Novato, CA), who used a 
novel mass spectrometric approach. 
 To determine whether glucose enhanced the acetylome, Bozena grew 
MC4100 strains in TB7 and TB7 supplemented with 0.4% glucose, harvested cells at 
5 time points over the course of two days (OD600 = 0.5 and 1.0 and 8, 24 and 32 
hours), prepared cell lysates, and subjected them to anti-acetyllysine Western im-
munoblot analysis (Fig. 16B). While she observed more bands across the entire 
growth curve under both growth conditions, Bozena came to the same general con-
clusion: glucose enhances the WT acetylome. These results were verified and quan-
tified by Drs. Schilling and Gibson, who applied mass spectrometry  analysis  to 
whole cell lysates from WT cells grown in TB7 or in TB7 supplemented with 0.4% 
glucose to OD600 = 1.0. In the absence of glucose, they detected 414 unique acetyl-
lysines in 194 proteins in the WT parent. In presence of glucose, they detected 965 
unique acetylation sites in 368 proteins. Thus, glucose enhances both the number of 
acetylations and the number of acetylated proteins. 
 To determine if the Pta-AckA pathway could affect protein acetylation, 
Bozena also performed anti-acetyllysine Western immunoblot analysis on cell ly-
sates from ackA and pta ackA double mutants grown over two days in TB7 (without 
glucose supplementation). Relative to its WT parent, the ackA mutant was hyper-
acetylated, especially during exponential growth (Fig. 16A). In contrast, the acety-
lome of the pta ackA mutant more closely resembled that of its WT parent. These 
data suggested that the enhanced acetylation exhibited by the ackA mutant was due 
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to the accumulation of AcP, but it also could be a direct result of the enzyme Pta. To 
distinguish between these two hypotheses, Bozena tested a pta mutant (which re-
tains AckA and thus the ability to accumulate AcP when exposed to exogenous ace-
tate). When cells were grown in TB7 supplemented with 10 mM acetate, the acety-
lome was considerably more robust (Fig. 16C). Taken together, these data implicate 
AcP as a regulator of acetylation. Since growth in the presence of glucose not only 
increases the concentration of AcCoA, but also that of AcP (64), Bozena asked 
whether glucose-induced acetylation required AcP. Indeed, the increased acetyla-
tion exhibited by WT cells when grown in TB7 supplemented with glucose was 
completely absent in the pta ackA mutant (Fig. 16B). These results were verified by 
mass spectrometry. In the absence of glucose, our collaborators detected 414 acety-
lation sites in 194 proteins from WT lysates, 932 acetylation sites in 379 ackA pro-
teins from ackA mutant lysates, but only 225 acetylation sites in 125 proteins from 
the pta ackA mutant. In the presence of glucose, mass spectrometry detected 965 
acetylated sites in 368 proteins from the WT parent but 2150 unique acetylation 
sites in 664 proteins from whole cell lysates derived from the ackA mutant. They did 
not analyze the pta ackA mutant grown in the presence of glucose. 
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 Among some of the proteins identified as differentially acetylated between 
WT and ackA mutants are all of the subunits of RNA polymerase. If RNA polymerase 
is indeed acetylated, one could imagine that its acetylation could affect transcription 
of many E. coli promoters, including cpxP. Therefore, I hypothesized that RNAP acet-
ylation affects the CpxA-independent, AcP-dependent cpxP transcription. 
 To verify that RNAP subunits are indeed acetylated, I grew the cpxA mutant 
and cpxA ackA double mutant (strain AJW 2794, Table 1) in the presence or absence 
of glucose, purified RNAP subunits α, β and β’ by immunoprecipitation, and sent the 
purified proteins to another collaborator (Dr. Haike Antelman) for mass spectrome-
try analysis. 
 From ackA cells grown in the presence of glucose, Dr. Antelmann and her 
group mapped 19 acetylation sites to β (Table 2), of which 12 were detected in at 
least two biological replicates. They mapped an additional 6 acetylation sites to β’, of 
which 4 were detected in two biological replicates (Table 2). And finally, they 
mapped 7 acetylation sites to α, of which 4 were detected in two biological repli-
cates (Table 3, Fig. 17). None of the reproducibly acetylated α sites was acetylated 
when ackA cells were grown in the absence of glucose (Tables 2 and 3). Dr. Antel-
mann’s group also detected glucose-dependent acetylation on RNAP subunits puri-
fied from WT cells, but the acetylation sites differed from those detected in the ackA 
mutant (Table 4). I will first describe my efforts to determine if acetylation could be 
responsible for the weak response to glucose exhibited by ackA mutants. Later, I will 
describe my investigation into the role that RNAP acetylation plays in WT cells. 
78 
 
 
 
 
LYS-291 ON RNAP αCTD CONTRIBUTES TO TRANSCRIPTION INHIBITION 
 To test the hypothesis that the weak response to glucose by ackA mutants 
requires one of the acetylated lysines of RNAP, I used site-directed mutagenesis to 
convert the acetylated lysines to alanine; therefore, preventing their acetylation. Be-
cause the gene that encodes α (rpoA) is essential for bacterial survival, I used a pre-
viously reported partial-diploid system (39) to test the hypothesis that one of the 
acetylated lysines on α inhibits cpxP transcription. This system keeps the WT copy 
of rpoA at its native site in the chromosome, and introduces mutant rpoA alleles into 
the cell via a multi-copy plasmid allowing one to determine if any given residue on α 
is involved in a particular behavior. 
 Into an ackA cpxA Φ(PcpxP’-lacZ) lysogen that carries the WT rpoA gene in its 
native location on the chromosome (strain AJW2794), I introduced plasmids carry-
ing either the WT rpoA allele or K-to-A point mutation derivative alleles (Table 1) 
with the goal of determining if any lysine functional group contributes to the weak 
response to glucose. I grew the resultant transformants in the absence or presence 
of 0.4% glucose and monitored β-galactosidase activity. cpxA ackA mutant cells that 
overexpressed the α K291A mutant responded robustly to the presence of glucose. 
In contrast, we observed little or no response from cpxA ackA mutants that overex-
pressed WT α, K-to-A mutations of the other 4 lysines of the αCTD (Fig. 18A) or K-
to-A mutations of the 3 acetylated lysines on the αNTD (data not shown). 
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 I also investigated whether Lys-291 could be responsible for the low cpxP 
response to 4% glucose in cpxA mutant cells (strain PAD348) whose Pta-AckA 
pathway remains intact. Indeed, cells that overexpressed the K291A variant yielded 
a stronger response to the presence of 4% glucose than did cells that overexpressed 
WT α (Fig. 18B). In contrast, Lys-291 was not required for the response to 0.4% 
glucose, as cpxA mutant cells that overexpressed either WT α or the K291A mutant 
responded at the same intensity (Fig. 18C). Therefore, whether caused by excessive 
glucose or by disruption of the Pta-AckA pathway, inhibition acts through Lys-291, 
perhaps due to its acetylation. 
 To determine if the requirement for Lys-291 could involve its acetylation, I 
took advantage of a genetic strategy commonly used in studies of eukaryotic protein 
acetylation (25). In this approach, the lysine (K) is converted to either a glutamine 
(Q) or an arginine (R). The KQ substitution mimics the neutral acetylated lysine, 
while the KR substitution mimics the positively charged unacetylated lysine. Con-
sistent with the hypothesis that Lys-291 acetylation inhibits glucose-induced cpxP 
transcription, cpxA mutant cells overexpressing the K291Q mutant variant of α re-
sponded to glucose with less intensity than did cells that overexpressed WT α or its 
K291A or K291R mutant variants (Fig. 18C). This decrease in cpxP transcription, 
however, cannot be explained by a decrease in steady state levels of the protein, 
since I did not observe any difference in their steady-state level (data not shown). 
These results lend support to the hypothesis the Lys-291 acetylation decreases the 
response to glucose by cpxP. 
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IS AN ACETYLTRANSFERASE  
REQUIRED FOR THE WEAK RESPONSE TO GLUCOSE? 
 In eukaryotes, protein acetylation is a reversible post-translational modifica-
tion that is balanced by the action of a protein acetyltransferase that adds an acetyl 
group to the Nε amino group of a lysine, and a protein deacetylase that mediates the 
hydrolysis of the acetyl group. Therefore, I hypothesized that Lys-291 acetylation 
would require the action of an acetyltransferase and predicted that overexpression 
of this acetyltransferase should inhibit cpxP transcription, even when the Pta-AckA 
pathway is intact, while deletion of such an acetyltransferase should promote a 
strong response to glucose in the ackA mutant. 
 To identify an acetyltransferase that participates in Lys-291-dependent inhi-
bition of cpxP transcription, I transformed WT cells with a set of multicopy plas-
mids; each plasmid expressed one of 22 known or predicted E. coli acetyltransferas-
es (Table 1). I grew the resultant transformants in the presence of glucose and IPTG 
(to induce acetyltransferase expression), and measured β-galactosidase activity. 
Relative to the WT strain carrying the vector control plasmid, overexpression of 8 
different acetyltransferases substantially inhibited the glucose response, while 
overexpression of only one increased the response (Fig. 19A and data not shown). 
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To test if one of these acetyltransferases was required for the weak response to glu-
cose by the ackA mutant, I deleted each acetyltransferase from the ackA mutant 
(strain AJW3994) and screened for double mutants whose cpxP promoter could re-
spond strongly to glucose. Only the ackA wecD double mutant exhibited strong cpxP 
transcription (Fig. 19B). However, this expression is unlikely to involve Lys-291 
acetylation as it occurred even in the absence of glucose (Fig. 19B inset). 
 On the basis of these results, I concluded that multiple acetyltransferases 
could inhibit glucose-induced cpxP transcription, but that no single tested acetyl-
transferase may be required for this inhibition. 
 
K291Q ALSO AFFECTS cpxP TRANSCRIPTION IN VITRO 
 The observed decrease in glucose-induced cpxP transcription, when I over-
expressed several acetyltransferases, supports the hypothesis that protein acetyla-
tion can inhibit cpxP transcription. This hypothesis is also supported by the de-
crease in transcription when Lys-291 of α was substituted by a glutamine, which is 
thought to be a genetic mimic of an acetylated lysine. However, it remained unclear 
whether this potential effect of protein acetylation was a direct or indirect effect on 
the glucose-induced cpxP transcription. To distinguish between these two possibili-
ties, I sought to first reconstitute cpxP transcription in vitro and then ask whether α 
K291Q had any effect in the in vitro transcription system. 
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 To establish the in vitro transcription system, I combined purified WT RNA 
polymerase containing σ70 (Eσ70) with purified WT or D51A CpxR, purified plasmid 
p770 carrying a DNA fragment that includes the cpxP promoter (Table 1) and AcP in 
an in vitro transcription buffer.  The reactions were incubated at 30°C for 15 
minutes and transcription was visualized by incorporation of [32P]-labeled UTP into 
the transcripts. To the extent that I tested, in vitro transcription of cpxP seems to 
have the same requirements as its in vivo transcription: AcP (Fig. 20), CpxR (Fig. 
21), and Asp-51 (Fig. 22) the phosphorylation site of CpxR. These results support 
the use of this system to test whether the effect of α K291Q on cpxP transcription is 
a direct or indirect effect.  To that end, I combined purified RNAP that contained 
αK291Q with purified WT CpxR, purified p770 carrying cpxP and AcP in an in vitro 
transcription buffer. The reactions were incubated at 30°C for 15 minutes and tran-
scription was visualized by incorporation of [32P]-labeled UTP into the transcripts. 
When compared to WT, RNAP that contained αK291Q was defective for cpxP tran-
scription. This defect in transcription, however, does not seem to affect the overall 
function of RNAP as rna1 transcription, which does not require the αCTD, seemed 
unaffected by the mutation at Lys-291 (Fig. 23). 
 The αCTD is an important transcription regulator and it does so by directly 
interacting with that UP element, an AT-rich region found in some but not all pro-
moters, and/or by directly interacting with transcription factors; in either case, the 
αCTD is thought to aid in the recruitment of the holoenzyme to the promoter region. 
Therefore, if αK291Q could somehow lead to a misfolded domain, this mutation 
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could affect virtually any promoter that requires the αCTD for proper regulation. 
However, this mutation could have more specific and targeted effects; for example, 
if the αK291Q does not cause any general folding defect. 
 To distinguish between these two possibilities, I took advantage of the large 
amount of molecular information available on the interaction between αCTD and 
the ribosomal RNA promoter rrnB. Proper transcriptional regulation of rrnB re-
quires the αCTD, but there is no evidence that Lys-291 plays any role in this regula-
tion.  Therefore, I predicted that if the defect in in vitro cpxP transcription, as seen 
with αK291Q, was due to improper CTD folding, then it also should affect rrnB tran-
scription in vitro. However, if αK291Q was able to properly fold its CTD, then rrnB 
transcription should not be affected, as αK291 is not involved in rrnB transcription. 
Consistent with the idea that αK291Q is capable of properly folding its CTD, there 
was no visible difference in rrnB in vitro transcription between reactions with WT 
RNAP and those with αK291Q RNAP. 
 On the basis of these results, I conclude that substitution of glutamine for ly-
sine at position 291 of α has a direct effect on cpxP transcription. Additionally, this 
defect seems to be specific to cpxP, as this substitution does not affect transcription 
of the rrnB promoter, which has been shown to require the αCTD, but not Lys-291. 
Since glutamine is considered a mimic of acetylated lysine and since Lys-291 is 
acetylated in the ackA mutant, I propose that acetylation of Lys-291 is responsible 
for the weak cpxP transcription observed in the ackA mutant. 
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CONCLUSION 
 I previously demonstrated that AcP could function as a phosphoryl donor, 
both in vitro and in vivo, to the RR CpxR. However, I hypothesized that this transfer 
of phosphoryl group was not the only regulatory mechanism involved in the CpxA-
independent, glucose-induced cpxP transcription. I had come to this hypothesis be-
cause ackA mutants failed to induce high cpxP transcription in response to the addi-
tion of glucose, even though CpxR was phosphorylated under these conditions. 
Thus, the goal of this chapter was to test the hypothesis that, in addition to CpxR 
phosphorylation, additional a regulatory mechanism(s) control(s) cpxP transcrip-
tion. The data presented here dismiss catabolite repression and implicate protein 
acetylation as that additional regulator, perhaps via Lys-291 of α. 
 With the help of Dr. Antelmann and her group, we determined that RNAP 
acetylation was enriched when WT and ackA mutant cells were grown in TB7 sup-
plemented with 0.4% glucose relative to unsupplemented TB7. The acetylated ly-
sines from both WT and ackA mutant samples were distributed throughout the 
RNAP subunits that we analyzed. However, the distribution was different in the two 
different strains. In each strain, some of the acetylations were located near sites that 
could impact RNAP function (i.e. the DNA binding patch of the αCTD and near the 
secondary channel between β and β’). This lends credence to the idea that acetyla-
tion could regulate activity. I tested this concept by converting each of the acetylated 
lysines of α to an alanine and learned that Lys-291 was involved in the weak re-
sponse to 0.4% glucose by the ackA mutant and in the response to 4% glucose by 
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the WT parent. Furthermore, conversion of lysine 291 to the acetylated lysine mimic 
glutamine (K291Q) inhibited cpxP transcription both in vivo and in vitro. Although 
the finding that αK291 is involved in dampening cpxP transcription when WT cells 
are exposed to 4% glucose leads me to hypothesize that Lys-291 involvement in the 
4% response is due to its acetylation, this hypothesis remains to be tested and at 
this point we do not have mass spectrometry evidence that Lys-291 becomes acety-
lated in the presence of 4% glucose. 
 If the K291Q substitution is a true mimic for acetylation of that residue, then 
the K291Q inhibition of cpxP transcription is evidence that RNAP acetylation direct-
ly impacts cpxP transcription, dampening it when compared to unacetylated RNAP. 
The effect of Lys-291 acetylation, however, does not seem to affect all αCTD-
dependent promoters, as the well characterized rrnB promoter was unaffected by 
αK291Q, even though its transcription requires the αCTD. 
 The mechanism by which K291 becomes acetylated in the ackA mutant back-
ground remains unknown. Overexpression of several known and putative acetyl-
transferases inhibited cpxP transcription in cells with an intact Pta-AckA pathway, 
yet deletion of no single acetyltransferase was sufficient to relieve the inhibition of 
cpxP transcription observed in ackA mutants. It is possible that multiple acetyltrans-
ferases could acetylate K291. Alternatively, acetylation of this residue might occur in 
a manner that does not require an acetyltransferase. This issue will be address in 
the next chapter. 
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 Although Lys-291 of α was the only tested lysine involved in cpxP transcrip-
tion, β and β’ are also widely acetylated. This raises the possibility that some of 
these acetylation events could also affect transcription. Additionally, α, β and β’ 
were also found to be acetylated even when the Pta-AckA pathway was intact, albeit 
on different residues, as long as the cells were grown in the presence of glucose. 
This raises the question: could any of these acetylation events of RNAP from WT 
cells also affect transcription from cpxP or from other promoters? This question will 
be addressed in the next chapter. 
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CHAPTER FIVE 
RESULTS 
ACETYLPHOSPHATE AS AN ACETYL DONOR 
I previously showed evidence that transcription of the cpxP promoter can be 
regulated both by the canonical CpxA-dependent phosphorylation of CpxR and by a 
CpxA-independent mechanism, via an AcP-dependent phosphorylation. I also pro-
vided evidence to support the hypothesis that this AcP-dependent behavior is 
modulated by acetylation of Lys-291 on the αCTD of RNAP. Acetylation of α Lys-291 
was detected when ackA mutant cells were grown in the presence of 0.4% glucose. 
Thus, I proposed that RNAP acetylation is a novel regulatory mechanism of the cpxP 
promoter. However, we also detected RNAP acetylation in WT cells that contained 
an intact Pta-AckA pathway. These observations raise the possibility that some of 
these WT acetylation events affect RNAP function. In this chapter, I will ask if glu-
cose-induced cpxP transcription can be affected by protein acetylation when the 
cells contain an intact Pta-AckA pathway. 
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cpxP TRANSCRIPTION RESPONDS TO ALTERATIONS IN THE ACETYLOME 
 To test the hypothesis protein acetylation affects cpxP transcription in WT 
cells, I exposed the cpxA mutant (strain PAD348) to increasing concentrations of nic-
otinamide, an inhibitor of NAD+-dependent sirtuin-like protein deacetylases. If pro-
tein acetylation influences cpxP transcription in WT cells, I would expect that this 
transcription would be affected by the addition of nicotinamide to the media. In sup-
port of the hypothesis that cpxP transcription is affected by protein acetylation, I ob-
served a CpxA- and glucose-independent increase in cpxP transcription that in-
creased as the concentration of nicotinamide increased, achieving more than a 4-fold 
induction at 50 mM nicotinamide, even in the absence of glucose (Fig. 24A). 
 Since nicotinamide can induce CpxA-independent cpxP transcription and glu-
cose can induce protein acetylation, I hypothesized that the glucose-induced cpxP 
transcription could involve protein acetylation. To test this hypothesis, I overex-
pressed the NAD+-dependent deacetylase CobB (pCA24n-cobB; Table 2) in WT cells 
(strain PAD282) grown in the presence of 0.4% glucose. If the cpxP response to glu-
cose requires protein acetylation, then cells that overexpress CobB should respond 
less strongly to glucose when compared to vector control. Indeed, overexpression of 
CobB reduced the 6-fold glucose-dependent induction to a more modest 3-fold induc-
tion (Fig. 24B). 
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 To determine whether the above mentioned treatments could influence the 
overall protein acetylation pattern, I used a cocktail of two polyclonal anti-
acetylated-lysine antibodies to detect overall protein acetylation via Western im-
munoblot analysis of whole cell lysates (Fig. 15). When WT cells (strain PAD282) 
were grown in the presence of either nicotinamide or glucose, the acetylome changed 
relative to cells grown without treatment. Glucose generally caused the number 
and/or intensity of acetylated bands to increase, as reported previously in chapter 3. 
In contrast, the deacetylase inhibitor nicotinamide induced more subtle changes. 
These subtle changes in the acetylation pattern correlated with a weaker response by 
the cpxP promoter to the addition of nicotinamide when compared to its response to 
glucose. CobB overexpression in cells exposed to glucose yielded a strong effect on 
the acetylation pattern. This acetylome closely resembled that of cells grown in the 
absence of glucose or nicotinamide. Thus, the conditions that influence cpxP tran-
scription correlate with a change in the E. coli acetylome. 
 
GLUCOSE-INDUCED cpxP TRANSCRIPTION  
REQUIRES A LYSINE ACETYLTRANSFERASE 
 In S. enterica, the NAD+-dependent deacetylase CobB works in conjunction 
with the GCN5-like acetyltransferase Pat to regulate the activity of the enzyme ace-
tyl-CoA synthetase (124, 125). The finding that CobB overexpression could inhibit 
cpxP transcription led us to hypothesize that glucose-induced cpxP transcription 
could be regulated by the E. coli Pat homolog, YfiQ. 
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 To test the hypothesis that YfiQ regulates glucose-induced cpxP transcription, 
I compared the glucose response of a mutant that lacks YfiQ (strain AJW3143; Table 
1) to that of its WT parent (strain PAD282). In contrast to its WT parent (approxi-
mately 3.5-fold induction), the yfiQ mutant responded poorly to glucose (approxi-
mately 1.5-fold induction) (Fig. 25). The requirement for YfiQ, however, did not ex-
tend to CpxA-dependent cpxP transcription, as surface-induced cpxP transcription 
was equivalent in both the yfiQ mutant and its WT parent (data not shown). Thus, 
the requirement for YfiQ is specific for the response to additional carbon. Therefore, 
I proposed that YfiQ and CobB catalyze the reversible acetylation of a protein, and 
that acetylation is required for glucose-induced cpxP transcription. 
 YfiQ and CobB are known to catalyze the reversible acetylation of acetyl-CoA 
synthetase (Acs) (124, 125). To test if Acs was involved in glucose-induced cpxP 
transcription, I deleted its gene; however, I did not observe any effect on cpxP tran-
scription (data not shown). This result was not surprising since acs transcription is 
inhibited by catabolite repression (73). I therefore sought the cpxP-relevant target 
of YfiQ and CobB elsewhere. 
 
YfiQ IS REQUIRED FOR IN VIVO ACETYLATION OF MULTIPLE LYSINES ON RNAP 
 The finding that protein acetylation was required for glucose-induced cpxP 
transcription, that RNAP is acetylated when WT cells is grown in the presence of 
glucose, and that acetylation of lys-291 of α seems to inhibit glucose-induced cpxP 
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transcription in the ackA mutant, led me to begin my search for the acetylation tar-
get(s) of YfiQ by asking whether glucose-induced RNAP acetylation required YfiQ. 
To that end, I grew WT and yfiQ mutant cells (strain AJW3143) in the absence or 
presence of 0.4% glucose, isolated the RNAP subunits by immunoprecipitation and 
subjected them to MS analysis. Using linear trap quadrupole (LTQ) Orbitrap mass 
spectrometry (MS), Dr. Haike Antelmann and her group first identified the acetyla-
tion sites on RNAP purified from WT cells. They mapped 15 glucose-dependent 
acetylation sites to β (Table 4), 11 acetylation sites to β’ (Table 4), and 2 acetyla-
tion sites to α (Fig. 26). None of these sites were acetylated when WT cells were 
grown in the absence of glucose. Of the 15 different acetylation sites detected from 
β, they detected 14 in at least two biological replicates. Of the 11 acetylation sites 
detected from β’, they reproducibly detected 8 (data not shown). Finally, α peptides 
containing acetylated Lys-297 or acetylated Lys-298 were detected in multiple bio-
logical replicates. Ten of the fifteen glucose-dependent β acetylations, ten of the 
eleven glucose-dependent β’ acetylations, and one of the two glucose-dependent α 
acetylations (Lys-298) required YfiQ (Table 4). Dr. Antelmann’s group detected no 
acetylated peptides from yfiQ mutant cells grown in the absence of glucose, which 
parallels the results with RNAP isolated from WT cells grown in the absence of glu-
cose.  Thus, I conclude that YfiQ is required for most of the glucose-induced acetyla-
tions of RNAP in vivo. 
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GLUCOSE-INDUCED TRANSCRIPTION REQUIRES LYS-298 OF THE αCTD 
 That acetylation of several lysines on RNAP is both glucose and YfiQ-
dependent led me to hypothesize that at least one of these residues could be re-
quired for glucose-induced cpxP transcription. To test this hypothesis, I focused my 
attention on α. I chose α due to its smaller size relative to β and β’, to our finding 
that acetylation of only one residue (Lys-298) was both glucose and YfiQ-dependent 
and to the finding that, under different conditions, an acetylatable α residue (Lys-
291) influences cpxP transcription. To test whether Lys-298 or any of the other four 
lysines on the αCTD were required for glucose-induced cpxP transcription, I intro-
duced plasmids that carry either the WT rpoA allele or lysine-to-alanine mutant de-
rivatives into the cpxA mutant (strain PAD348), which carries the WT rpoA gene at 
its native location on the chromosome. I grew the resultant transformants in the ab-
sence or presence of 0.4% glucose and compared the β-galactosidase activity of cells 
expressing each lysine-to-alanine substitution to that of cells expressing WT α. Of 
the five mutants tested, only K298A exerted a defect on glucose-induced cpxP tran-
scription (Fig. 27A). 
 To ensure that the K298A mutant retained function, I tested if a CpxA-
dependent stimulus (i.e., exposure to alkaline pH) could induce cpxP transcription in 
cells WT for CpxA (strain PAD282). Indeed, cells expressing the K298A mutant acti-
vated cpxP transcription when grown in TB buffered at pH 7.8, but not in TB buff-
ered at pH 7.0 and supplemented with glucose. In contrast, cells expressing WT rpoA 
activated cpxP transcription under both conditions (Fig. 27B). 
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 I further tested whether the loss of glucose-induced cpxP transcription ob-
served with the K298A mutant was due to a dominant-negative effect by measuring 
β-galactosidase activity of cells that carried a mutant α lacking its CTD. Into the cpxA 
mutant (PAD348), I introduced plasmids that carry either the WT rpoA allele or a 
mutant derivative with the CTD and the linker region deleted. I grew resultant 
transformants in the absence or presence of glucose and measured β-galactosidase 
activity. Like the K298A mutant, the αCTD deletion mutant exhibited a defect in glu-
cose-induced cpxP transcription (Fig. 27C). I interpreted these results to mean that 
K298A allele encodes a functional form of αCTD and that Lys-298 is required for 
glucose-induced cpxP transcription, but not for CpxA-induced transcription, perhaps 
because Lys-298 needs to be acetylated under these conditions. 
 
YfiQ DOES NOT ACETYLATE RNAP IN VITRO 
 The finding that YfiQ and Lys-298 of α were required for glucose-induced 
cpxP transcription and that YfiQ was required for Lys-298 acetylation in vivo, led me 
to hypothesize that YfiQ directly acetylated Lys-298. To test this hypothesis I at-
tempted to acetylate α by incubating purified His6-YfiQ, [14C]-labeled AcCoA, and 
Eσ70 into the in vitro transcription buffer for 1 hour at 37°C. However, in spite of my 
efforts, I was unable to obtain any evidence that YfiQ acetylated α, or any other 
RNAP subunit, under my experimental conditions. This raises that possibility that 
RNAP is not directly acetylated by YfiQ. 
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AcP AS AN ACETYL DONOR 
 My inability to acetylate RNAP in vitro using YfiQ as the acetyltransferase and 
AcCoA as the acetyl donor, led me to consider the possibility that YfiQ does not di-
rectly acetylate RNAP and that the observed effect on in vivo RNAP acetylation, 
when YfiQ was deleted, was an indirect effect. 
 Several factors led me to consider the possibility that AcP itself was the ace-
tyl donor to RNAP. (i) Western immunoblot analysis conducted by Bozena 
Zemaitaitis and quantitative mass spectrometry performed by Birgit Schilling in 
Bradford Gibson’s lab (Buck Institute of Aging) demonstrated that the accumulation 
of intracellular AcP correlates with a dramatic increase in total protein acetylation. 
(ii) Linda Hu (from our lab) possesses evidence that the central metabolite protein 
LpdA can be acetylated in vitro in an AcP-dependent and acetyltransferase-
independent manner. (iii) Misty Kuhn and Michael Scholle from the labs of Wayne 
Anderson and Milan Mrksich (Northwestern University) possess evidence that AcP 
can function as a direct acetyl donor to linear peptides containing a lysine. 
 To test if AcP could function as an acetyl donor to RNAP, I incubated Eσ70 in 
in vitro transcription buffer with increasing concentration of AcP at 30°C for 1 hour 
and detected RNAP acetylation via Western immunoblot analysis. Consistent with 
the hypothesis that AcP can function as an acetyl donor to RNAP, I detected an in-
crease in the acetylation of β and/or β’ as the concentration of AcP in the reaction 
increased. This result could help explain a conundrum that in vivo cpxP transcription 
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requires an acetylation event; however, in vitro transcription occurs in the absence 
of an acetyltransferase or AcCoA (Fig. 28). 
 
CONCLUSION 
There are over 300 known posttranslational modifications (143). Protein 
phosphorylation is likely the most studied of all these posttranslational modifica-
tions. However, in the recent years, protein acetylation has been gaining increased 
attention in all domains of life. Based on global proteomics studies [(68, 139, 155, 
157) and Schilling, Gibson and Wolfe, unpublished], protein acetylation is likely to 
affect many proteins that play important roles in E. coli and S. enterica physiology. In 
E. coli, some of these proteins are the subunits of RNAP. 
In chapter 4, I provided evidence that supports the hypothesis that acetyla-
tion of Lys-291 of the α subunit of RNAP inhibits glucose-induced cxpP transcription 
in ackA mutants. In this chapter, I extended the effect of protein acetylation and 
perhaps of RNAP acetylation to include glucose-induced cpxP transcription from 
cells that contain a WT Pta-AckA pathway. 
Mass spectrometry analysis conducted by Dr. Haike Antelmann’s group 
demonstrated that glucose-induced acetylation of several lysines on α, β and β’ re-
quired the acetyltransferase YfiQ. Among the sites affected by deletion of yfiQ is Lys-
298 of α and conversion of Lys-298 to an alanine had profound impact in glucose-
induced cpxP transcription. YfiQ is also required for glucose-induced cpxP transcrip-
tion. Thus, together these data support the hypothesis that glucose-induced cpxP 
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transcription is dependent on the YfiQ-dependent acetylation of α Lys-298. Lys-298 
is important also for transcription of the rRNA promoter rrnB. At the rrnB promoter 
Lys-298 makes direct contact with the DNA backbone. Thus, acetylation of this resi-
due could potentially have broad impact in E. coli physiology. 
Despite being required for acetylation of approximately 70% of the lysines 
acetylated by glucose, including Lys-298, I was unable to obtain in vitro evidence 
that YfiQ directly acetylates any of those lysines. This raises the possibility that the 
YfiQ effect on RNAP acetylation is indirect. In fact, my data indicate that AcP is more 
likely to be directly responsible for RNAP acetylation than YfiQ, as I was able to de-
tect, by Western immunoblot analysis, an increase in acetylation of β and/or β’ 
when RNAP was incubated with increasing concentration of AcP. Additional analy-
sis, via mass spectrometry, is required to determine if other RNAP subunits are also 
acetylated by AcP and if so their identity. 
AcP had previously been proposed to play an important role in E. coli physi-
ology due to its ability to donate its phosphoryl groups to some response regulators 
in vitro. In chapter 3, I demonstrated that this transfer of phosphoryl group from 
AcP to RRs also occurs in vivo to the RR CpxR. However, based on evidence present-
ed in this chapter, this AcP-dependent phosphorylation seems to be modulated by 
another AcP-dependent posttranslational protein modification, the acetylation of 
RNAP. This acetylation sees to function in some sort of balancing acting, modulating 
the strength of the AcP-dependent cpxP transcription. 
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The E. coli genome is predicted to encode over 20 known or putative Gcn5-
like acetyltransferases. Of those, YfiQ is likely the best characterized, and is the only 
one to be demonstrated to possess Nε lysine acetylation capabilities. However, glob-
al mass spectrometry analysis performed by Birgit Schilling and Bradford Gibson 
detected only a 10-20% reduction in the total number of proteins acetylated when 
yfiQ was deleted from E. coli cells grown in the presence of 0.4% glucose. In contrast, 
deletion of ackA doubled the number of acetylated proteins, under the same condi-
tions, and deletion of both pta and ackA decreased the number of total acetylated 
proteins by 50% in the absence of glucose.  Thus, I concluded that, under the tested 
condition, AcP has a more important role in protein acetylation than the acetyltrans-
ferase YfiQ. This effect is likely to be a combination of direct and indirect acetylation 
as transcription of the putative acetyltransferase YafP is increased in cells that ac-
cumulate AcP and AcP can serve as the acetyl donor for at least two proteins in vitro, 
LpdA and RNAP. 
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CHAPTER SIX 
DISCUSSION 
OVERALL SUMMARY 
As part of the long-term effort by the Wolfe laboratory to map the impact of 
AcP on the network of E. coli 2CST pathways, I discovered that AcP has a significant 
effect on CpxR-dependent transcriptional regulation of cpxP.  The evidence I pre-
sented here supports a model in which AcP plays a pivotal role in the transcription 
regulation of cpxP via both phosphorylation of the RR CpxR and acetylation of RNAP. 
These two PTMs seem to work together to fine tune cpxP transcription as the inten-
sity of the AcP-dependent cpxP transcription seems to be affected by acetylation of 
different lysine residues on the αCTD. While the hypothesis that AcP can phosphory-
late and therefore control the activity of multiple response regulators has been pro-
posed before (90, 91), the notion that AcP can also serve as an acetyl donor is fairly 
novel. This newly identified role for AcP has the potential to open several new lines 
of investigation. Some questions come to mind: What is the overall impact of this 
AcP-dependent acetylation? It seems evident that RNAP acetylation has the poten-
tial to affect multiple aspects of E. coli physiology. How many more proteins are 
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acetylated in the same manner? Some recent data from the Wolfe laboratory 
demonstrate that AcP has a large impact on the overall protein acetylation status of 
E. coli, as demonstrated by Western immunoblot analysis and mass spectrometry 
analysis. How prevalent is AcP-dependent acetylation when compared to AcCoA-
dependent acetylation? Does AcP-dependent acetylation occur in other organisms? 
The Wolfe laboratory has started to address some of these questions and, 
based on some of the data obtained so far, it seems like AcP has a broader impact in 
E. coli physiology than previously appreciated. 
 
SIGNAL INTEGRATION 
On the basis of my observations and previously published reports, I propose 
that the CpxAR pathway integrates multiple signals at three distinct levels. (i) In the 
periplasm, CpxP integrates stimuli predicted to cause misfolding of envelope pro-
teins [for reviews, see references (31, 32, 106, 115)]. (ii) At the cytoplasmic mem-
brane, the periplasmic domain of CpxA integrates information concerning the status 
of the periplasmic chaperone CpxP with signals that depend on the outer membrane 
lipoprotein NlpE and with stimuli that depend on neither CpxP nor NlpE (11, 30, 98, 
107, 110, 151). (iii) Finally, in the cytoplasm, CpxR integrates the above mentioned 
CpxA-dependent signals with those that are independent of CpxA (e.g., entry into 
stationary phase and exposure to excess carbon (23, 149).  
It has been reported previously that entry into stationary phase generates a 
CpxA-independent response (11, 14). The nature of the response, however, has re-
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mained elusive. The response of cells grown in glucose minimal media buffered with 
phosphate depends in part on σS (28), while the response of cells grown in LB does 
not (30). Like LB, TB is based on tryptone. Furthermore, σS is not fully functional 
this early in the transition to stationary phase, at least during growth in LB (142). 
Finally, deletion of both CpxA and the Pta-AckA pathway reduced growth-dependent 
cpxP activity to levels that resembled those of cpxR mutants (Fig. 5A). Thus, as cells 
enter stationary phase, cpxP becomes activated in response to both CpxA-dependent 
and Pta-AckA-dependent stimuli. This raises an intriguing question. During normal 
growth in a tryptone-based broth, why and how would CpxRA signaling respond to 
both envelope-associated and growth-associated cues?  
Cells experience multiple stimuli that impact the phosphorylation status of 
RRs, including CpxR. Thus, the CpxR-dependent behavior of WT cells represents an 
integration of all these stimuli, and efforts to dissect this and other complex path-
ways must take this into account.  
It is difficult to imagine that this complex signal integration is a privilege of 
the CpxAR pathway. In fact, evidence from the Wolfe laboratory suggests that at 
least one other 2CST pathway, the Rcs (Regulator of Capsule Synthesis) phosphore-
lay, also possesses a highly intricate and sophisticated mechanism to integrate sig-
nals that originate from the outer and inner membranes, periplasm and cytoplasm. 
The Rcs phosphorelay activates genes required for capsular biosynthesis (47) and 
multiple stresses (10, 26), while repressing genes required for flagellar biogenesis 
(37). Published evidence demonstrated that the RR RcsB can be both phosphory-
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lated and acetylated, and that both modifications can affect the function of this pro-
tein (38, 130). RcsB phosphorylation can occur via the canonical SK-dependent 
phosphorylation or via an AcP-dependent mechanism (38, 146). Parallel to what I 
demonstrated for CpxR, multiple observations support the hypothesis that AcP-
dependent RcsB phosphorylation occurs on the conserved Asp residue that func-
tions as the phosphoacceptor for sensor kinase-dependent phosphotransfer (Hu, L. 
I. and Wolfe, A. J. unpublished data).  It is the acetylation of RcsB that seems to chal-
lenge all previously established rules and concepts regarding protein acetylation. In 
vitro, acetylation can occur via an YfiQ-dependent transfer of the acetyl group from 
AcCoA to Lys-180 of the DNA-binding motif of RcsB (130). In vitro, however, the 
transfer of acetyl groups from AcCoA to RcsB also seems possible in the absence of 
any acetyltransferase (Hu, L. I. and Wolfe, A. J. unpublished data); this mechanism 
might be similar to the autoacetylation processes proposed for ACS and CheY (4). An 
additional autoacetylation mechanism seems to use AcP as the acetyl donor, Linda 
Hu possesses evidence that LpdA can be acetylated using acetyl groups from AcP 
and I demonstrated that the same can occur to RNAP (Chapter 5). In fact, recent data 
from the Wolfe laboratory demonstrate that AcP has a large impact on the overall 
protein acetylation status of E. coli (Bozena Zemaitaitis and Alan J. Wolfe, un-
published data). It remains to be determined how much of this impact is direct, as 
seems to be the case for RNAP and LpdA acetylation, and how much of the impact is 
indirect.  
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THE LOSS OF THE Pta-AckA PATHWAY 
Disruption of the Pta-AckA pathway is likely to have many effects in E. coli 
metabolism and therefore the overall physiology of the cell.  The Pta–AckA pathway 
does more than simply synthesize AcP. During acetogenesis, this pathway recycles 
CoA, generates ATP, and evolves acetate [reviewed in (144)]. E. coli produces limit-
ing amounts of CoA; therefore, cells must recycle CoA to maintain glycolytic flux, and 
loss of the Pta-AckA pathway removes their “favored” option, at least at neutral pH, 
potentially leading to accumulation of AcCoA [review in (144)]. 
In many respects, mutants that lack AckA or both Pta and AckA behave simi-
larly. In batch culture, they excrete little or no acetate, and they limit their produc-
tion of ethanol. Instead, they both excrete pyruvate, lactate, and glutamate, a behav-
ior that might be explained by the observation that these mutants exhibit increased 
expression and activity of key glycolytic and TCA cycle enzymes [reviewed in  
(144)]. Surprisingly, they do not increase expression of their CoA biosynthetic ma-
chinery (148), nor do they alter their AcCoA pool relative to that of their WT parent 
(72). The increased expression and activity of both glycolytic and TCA cycle en-
zymes and the altered excretion profile suggest that cells attempt to compensate for 
the loss of the Pta-AckA pathway (148). This loss of the pathway by the cells and 
their attempt to compensate for it can make the interpretation of some phenotypes 
associated with AcP a little challenging. In fact, some studies provide some evidence 
for pathway involvement but fail to make a strong connection to AcP [for a review, 
see reference (145)]. Similarly to what I found for CpxAR signaling, some further in-
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vestigation of these pathways may discover new mechanisms that involve more 
than just AcP-dependent phosphorylation of RRs and might also involve more than 
just 2CST. 
 
AcP-DEPENDENT PHOSPHORYLATION 
Plenty of evidence exists that AcP can readily phosphorylate RRs in vitro 
(144). In vivo, AcP-dependent behaviors have been reported in diverse bacteria, in-
cluding pathogens [for example, (99, 150)]. In E. coli for example, the regulation of 
about approximately 100 genes correlates with the status of AcP (148). However, 
the evidence for a transfer of phosphoryl group from AcP to some RR, in many cases, 
is either weak or nonexistent [reviewed in (146)]. Some of the challenges in demon-
strating the role of AcP as a global signaling molecule comes from the pivotal role 
AcP plays in central metabolism, which has made the interpretation of some of the 
phenotypes related to disruption of the Pta-AckA pathway challenging. Additional 
challenges can be attributed to the labile nature of the acyl phosphate bond present 
in phospho-Asp modification (1), which has hindered the development of antibodies 
capable of detecting phosphorylated RRs and made it difficult to obtain definitive 
evidence of an AcP-dependent phosphorylation of RR in vivo.  
Relatively recent biotechnological advances have the potential to facilitate 
the detection of phosphorylated RRs in vivo and allow for a more definitive test of 
the hypothesis that AcP acts as a phosphoryl donor to RRs in vivo. In 2006, Kinoshita 
et al. optimized a method to detect phosphorylated proteins by mobility shift assay. 
115 
 
 
 
This method consists of introducing a phosphate-binding tag (Phos-TagTM) bound to 
acrylamide beads into SDS-PAGE gels. The Phos-TagTM molecules, with the help of 
Zn2+ or Mn2+, preferentially interact with molecules with phosphomonoester bonds 
as seen in proteins with phosphorylated Ser, Thr and Tyr side chain residues, slow-
ing the electrophoretic migration of these proteins through a gel (70).  In 2008, 
Barbieri and Stock utilized phos-tagTM to detect the labile phosphorylation of the E. 
coli RR PhoB both in vitro, using purified protein, and in vivo, using cell lysates (5). 
Using this methodology, Liu et al. demonstrated that, consistent with the notion that 
CpxA function as a phospho-Asp phosphatase in vivo, phosphorylation of Yersinia 
pseudotuberculosis CpxR, expressed from a plasmid vector, increased in a cpxA mu-
tant background when compared to the WT parent. This finding corroborates what 
has been demonstrated in vitro (36, 111) and proposed in vivo (6, 17, 23, 24, 149). 
Liu et al. (2011) also demonstrated that this CpxA-independent phosphorylation re-
quired the Pta-AckA pathway, but failed, however, to perform a complete epistasis 
analysis (85).  
I extended the results of Liu et al (2011) by demonstrating that, in E. coli, 
endogenously expressed CpxR becomes phosphorylated in a glucose-dependent 
manner independently of the SK CpxA. Using a plasmid-born CpxR, I demonstrated 
that the glucose-induced phosphorylation requires the conserved Asp-51 residue. I 
also conducted a complete epistasis analysis of the Pta-AckA pathway effect on 
glucose-induce CpxR phosphorylation and concluded that this phosphorylation 
requires AcP. This conclusion was based on the presence of phosphorylated CpxR 
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when cells accumulated AcP, whereas complete deletion of the Pta-AckA pathway 
led to almost undetectable levels of phospho-CpxR. However, I acknowledge the 
existence of a weak glucose- and AcP-independent signal exhibited by the pta ackA 
double mutant. Currently, we do not know the origin of this weak signal. Perhaps, 
under the conditions tested, a small percentage of CpxR is phosphorylated by a non-
cognate sensor kinase and/or another small phospho-donor. 
Lastly, while the use of Phos-TagTM requires some optimization, at the pre-
sent moment, this is likely the best and most accessible approach to detect phos-
phorylated RRs in vivo. 
 
PROTEIN ACETYLATION IS AN IPORTANT CONTRIBUTOR  
TO cpxP TRANSCRIPTION 
 In addition to being regulated via CpxA- and/or AcP-dependent phosphoryla-
tion, I propose that cpxP activity also is regulated via an N-lysine acetylation. 
 Exposure to glucose can induce cpxP transcription in a sensor kinase-
independent manner. While one might initially consider the involvement of catabo-
lite repression in glucose-induced cpxP transcription, the observation that both ca-
tabolite-repressing and non-catabolite-repressing carbon sources (e.g. glucose and 
acetate, respectively) can trigger CpxA-independent cpxP transcription argues 
against it. Instead, this finding focused my attention on the alternative hypothesis 
that transcription-activating carbon sources contribute to cpxP transcription via an 
acetylation event. I base this proposition on the following evidence: (1) growth in 
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the presence of excess glucose leads to an increase in the overall protein acetylation 
status that can be detected via mass spectrometry analysis and Western immunob-
lot analysis. (2) exposure to the NAD+-dependent deacetylase inhibitor nicotinamide 
induces cpxP transcription in the absence of glucose or other carbon sources, (3) 
overexpression of the NAD+-dependent deacetylase CobB inhibits glucose-induced 
cpxP transcription, and (4) glucose-induced cpxP transcription specifically requires 
the GCN5-like acetyltransferase YfiQ and a lysine residue 298 located on the surface 
of the  αCTD that, under my tested growth condition, is acetylated in a glucose- and 
YfiQ-dependent manner. 
 Although I demonstrated that glucose-induced cpxP transcription is affected 
by CobB and YfiQ, the mechanism behind this effect remains unclear. Exposure to 
glucose altered the acetylation status of multiple proteins. This was observed as an 
increase in the number and/or intensity of acetylated bands as detected by Western 
immunoblot analysis. Glucose also induced a two-fold increase in the number of 
proteins and lysines detected to be acetylated by mass spectrometry (B. Schilling, B. 
Gibson, and A. J. Wolfe, unpublished data). Unlike glucose, the CobB inhibitor nico-
tinamide caused relatively few changes in the total acetylation profile, as previously 
reported (157). Thus, nicotinamide and therefore CobB inhibition likely exert a 
more limited effect on the E. coli acetylome than does glucose. This marginal effect 
of CobB on overall protein acetylation was quantified by mass spectrometry analy-
sis. In general, deletion of CobB promoted a 10% increase in overall protein acetyla-
tion in the absence of glucose and approximately 20% when the cells were grown in 
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the presence of glucose (B. Schilling, B. Gibson, and A. J. Wolfe, unpublished data). 
Several factors could contribute to this observation: (1) the deacetylase CobB might 
have a limited number of acetylated targets, whereas the additional AcCoA could be 
used as an acetyl donor by multiple acetyltransferases; (2) CobB might not be fully 
expressed and active when the samples were collected for analysis; and (3) present-
ly unidentified deacetylases could exist (L. I. Hu and A. J. Wolfe, unpublished data). 
Under any of these circumstances, inhibition of the deacetylase CobB would not be 
expected to exert a large impact on the acetylome. It should be noted, however, that 
CobB overexpression antagonized glucose-induced acetylation. This behavior is 
consistent with one of three possibilities: (1) CobB could directly reverse glucose-
induced acetylations, (2) CobB could activate another deacetylase(s) that reverses 
those acetylations, or (3) CobB could inhibit the acetyltransferase(s) responsible for 
those acetylations. 
 Glucose-induced cpxP transcription requires YfiQ, and YfiQ is required for 
approximately 75% of the glucose-induced Lys acetylation on RNAP; however, I was 
unable to obtain evidence that YfiQ can directly acetylate RNAP in vitro. This inabil-
ity to directly acetylate RNAP with YfiQ in vitro makes me favor the possibility that 
the YfiQ effect on RNAP acetylation is indirect. Indeed, the Wolfe laboratory pos-
sesses evidence that YfiQ inhibits glycolysis, which would diminish the concentra-
tion of AcP (A. J. Walker-Peddakotla, M. Kuhn, W. F. Anderson and A. J. Wolfe, un-
published data). 
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 The pattern of RNAP acetylation is affected by disruption of the Pta-AckA 
pathway. One of the key residues under these conditions is α Lys-291. Under 
conditions that promote Lys-291 acetylation, cpxP transcription is diminished. 
Contrary to what I observed for Lys-298, I found no evidence that YfiQ plays any 
role in Lys-291-dependent inhibition of cpxP transcription. Although 
overexpression of YfiQ promoted a small increase in glucose-induced cpxP 
transcription, it did not alter the weakened response by the ackA mutant. This 
weakened response also was unaffected by deletion of yfiQ. Although, 
overexpression of several acetyltransferases inhibited cpxP transcription in the WT 
parent, deletion of any single enzyme did not permit the ackA mutant to respond 
robustly to glucose.  A simple explanation for these results is that multiple 
acetyltransferases could acetylate Lys-291; however, at this point, I have identified 
no acetyltransferase that could acetylate RNAP. Alternatively, Lys-291 could become 
acetylated independently of the action of an acetyltransferase. Efforts to distinguish 
between these two mechanisms are underway. Indeed, quantitative mass 
spectrometry revealed that Lys-291 is hyperacetylated in the glucose-exposed ackA 
mutant relative to its WT parent (B. Schilling, B. Gibson, and A. J. Wolfe, unpublished 
data). 
 To date, YfiQ is the only E. coli acetyltransferase with confirmed protein 
acetyltransferase activity. However, under the conditions I tested (TB supplemented 
with 0.4% glucose), YfiQ only affected the acetylation of approximate 10% of pro-
teins when compared to WT, as detected by mass spectrometry analysis (B. Schil-
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ling, B. Gibson, and A. J. Wolfe, unpublished data). Some of the proteins acetylated by 
YfiQ are proteins involved in the switch between glycolysis and gluconeogenesis, 
leading to the hypothesis that YfiQ contributes to the regulation of central metabolic 
pathways. Indeed, in support to this hypothesis, YfiQ mutants possess a growth de-
fect under certain limiting nutritional conditions, when compared to WT (Walker-
Peddakotla, A. J. and Wolfe A. J., unpublished). Changes in carbon sources that are 
supplemented into the media can alter the acetylation patterns of more than 100 
proteins in both E. coli and Salmonella. This change in acetylation has been proposed 
to lead to change in the direction of carbon flux to glycolysis or gluconeogenesis and 
control the activity of the glyoxylate shunt relative to the tricarboxylic acid cycle 
[reviewed in (132)]. Thus, it is possible that the YfiQ effect on RANP acetylation 
could be derived from an YfiQ effect in central metabolism. 
 The link between central metabolism and YfiQ goes beyond the YfiQ in-
volvement in the acetylation of some metabolic proteins. Recent evidences suggest 
that, in E. coli, YfiQ transcription is affected by the concentration of cyclic AMP, link-
ing transcription regulation of this acetyltransferase to central metabolism. It was 
proposed that this regulation occurs via CRP, as the putative yfiQ promoter contains 
two CRP binding elements that are required for yfiQ transcription (18). In contrast, 
in M. tuberculosis, cAMP directly activates the YfiQ homologue Mt-PatA, by binding 
to a cyclic nucleotide–binding domain fused to the N terminus of the catalytic PAT 
domain (75, 96). Efforts to understand the connection between YfiQ, cAMP, central 
metabolism, and protein acetylation are underway. 
121 
 
 
 
 
AcP-DEPENDENT ACETYLATION 
 The data presented here support the hypothesis that AcP affects the overall 
protein acetylation status of E. coli. RNAP isolated from ackA mutant cells exhibited 
a vastly different acetylation pattern than RNAP isolated from the WT parent. A sim-
ilar observation has been made for RcsB (L. I. Hu and A. J. Wolfe, unpublished data). 
On the basis of these observations, anti-acetyl-lysine Western blot and mass spec-
trometric analyses were performed on an isogenic set of strains that included mu-
tants defective for the Pta-AckA pathway and the known acetylation-associated en-
zymes (B. Zemaitaitis, B. Schilling, B. Gibson, and A. J. Wolfe). Western blot analysis 
provided evidence that AcP is a major regulator of protein acetylation in E. coli. 
Whenever AcP levels were increased (i.e., in an ackA mutant grown in TB or in a pta 
mutant gorwn in TB supplemented with acetate, or in WT cells grown in TB sup-
plemented with glucose), global acetylation increased. Mass spectrometric analysis 
extended and quantified those observations. For example, the number of proteins 
detected as acetylated by mass spectrometry analysis was 90% greater in cell ly-
sates from the ackA mutant than from its WT parent. This increase in protein acety-
lation was observed whether glucose was present or not. Consistent with the notion 
that this increase in protein acetylation is an AcP-dependent phenotype, the pta 
ackA double mutant exhibited a major decrease in the total number of detected 
acetylated proteins to a total of only 60% of the WT level, when the cells were 
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grown in the absence of glucose. Finally, Western immunoblot analyses showed that 
most of the glucose-dependent acetylation required AcP.  
 This AcP-dependent increase in detectable acetylated proteins could be ex-
plained by a combination of any of the following possibilities: (1) AcP could induce 
an increase in the expression and/or activity of an AcCoA-dependent protein acetyl-
transferase, (2) AcP could function as an acetyl donor for a presently unidentified 
acetyltransferase, (3) or AcP could directly transfer its acetyl group to the target 
protein.  
 Whichever the mechanism, initial analyses demonstrate that approximately 
7% of total E. coli proteins are acetylated in the ackA mutant. This number jumps to 
approximately 12% when the cells are grown in the presence of glucose. This num-
ber is likely to be an underestimate as this represents a snapshot of the acetylome as 
the cells enter stationary phase. Additionally, due to inherent limitations of the ap-
proach used, proteins found in very low concentration may not have been detected 
by this mass spectrometry analysis, which would also contribute to an underesti-
mate of the total number of acetylated proteins.  
 RNAP is among some of the proteins whose acetylation has been shown to be 
affected by disruption of the Pta-AckA pathway. This evidence comes from mass 
spectrometric analysis of RNAP purified from immunoprecipitation and also from 
RNAP that present in cell lysates. Although my results implicated approximately 
75% of the acetylation sites on RNAP to YfiQ, my attempts to reconstitute this reac-
tion in vitro with purified proteins have failed. Instead, as detected by Western im-
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munoblot analysis, in vitro acetylation of some RNAP subunits occurred when AcP 
was added to the reaction as the acetyl donor. Since I cannot completely discard the 
possibility that my purified protein samples could be contaminated with a protein 
that uses AcP as an acetyl donor to acetylate proteins, my finding that addition of 
AcP to purified RNAP leads to its acetylation lends support to two of the three pos-
sibilities presented above: (a) An acetyltransferase could use AcP to acetylate pro-
teins in vivo, or (b) AcP could acetylate these proteins directly. Lastly, it is important 
to mention that although I was unable to acetylate RNAP in vitro using AcCoA as the 
acetyl donor and YfiQ as the acetyltransferase, I cannot discard the possibility that 
this reaction may occur in vivo and that I may have not found the appropriate in 
vitro condition to reproduce it.  
 It remains untested if the AcP-dependent acetylation of RNAP has any effect 
on its activity in vivo. While the data I presented here support the hypothesis that 
acetylation of Lys-298 and Lys-291 contributes to the regulation of cpxP transcrip-
tion, I cannot yet say whether the acetyl group for these acetylation events come 
from AcCoA or from AcP. Mass spectrometry analysis of in vitro acetylated RNAP is 
currently underway to determine if AcP can acetylate either of these residues in 
vitro. Independently of where the acetyl groups for acetylation of Lys-298 and Lys-
291 come from, I did observe an AcP-dependent effect on RNAP activity in vitro, 
marked by a progressive decrease in rna1 transcription as the concentration of AcP 
in the reaction increased. This effect is likely to be context dependent as AcP had the 
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opposite effect on cpxP transcription, leading to a dose-dependent increase in cpxP 
transcription. 
 If AcP can indeed directly acetylate proteins in vivo, one could easily imagine 
that if not properly regulated this acetylation could have some negative impact on 
overall cellular physiology. One likely candidate to help the cells regulate AcP-
dependent acetylation is the deacetylase CobB. In an in vitro assay, purified CobB 
has been shown to be capable of deacetylating short peptides that had been previ-
ously acetylated using AcP as the acetyl donor (M. Kuhn, M. Scholle, M. Mrksich, W. 
F. Anderson, A. J. Wolfe, unpublished data). Thus, it is possible that, in a manner par-
allel to the phospho-Asp phosphatase activity of some SKs, the deacetylase CobB 
may help maintain the proper levels of certain acetylated proteins by deacetylating 
proteins that have been previously acetylated by AcP. Indeed, evidence from the 
Wolfe laboratory supports the hypothesis that CobB deacetylates some AcP-
dependent lysine acetylations (A. AbouElfetouh, D. Christensen, and A. J. Wolfe, un-
published data).  
  
A ROLE FOR ACETYLATED Lys-298 
 Following enrichment by immunoprecipitation, mass spectrometry analysis 
revealed acetylation of several surface-exposed lysines of the β, β’, and α subunits of 
RNAP isolated from WT cells exposed to glucose. Due to its smaller size and the fact 
that only two lysines were found to be acetylated, I further investigated the effect of 
αCTD acetylation on cpxP transcription. Using a merodiploid system, I asked wheth-
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er any of the Lys on αCTD played a substantial role in glucose-induced cpxP tran-
scription and found that Lys-298 did. Expression of the K298A mutant inhibited 
transcription, whereas similar expression of the other α K-to-A mutants, including 
the alanine mutant of Lys-297, which was also found to be acetylated, had no signifi-
cant effect on glucose-induced cpxP transcription. Furthermore, the requirement for 
Lys-298 was specific: extracytoplasmic stimuli that activate CpxA kinase activity and 
thus rapid phosphorylation of CpxR did not require Lys-298. 
The findings presented here substantially add to data presented by previous 
reports that RNAP subunits can become acetylated (155, 157). It also establishes at 
least one growth condition under which these acetylation events likely occur and 
implicate the acetyltransferase YfiQ in acetylation of the majority of those sites, in-
cluding Lys-1200 of β, which had been previously reported to be acetylated (157). 
However, at this moment it is not clear if YfiQ is a direct or indirect contributor to 
these acetylations. 
 It is also unclear what percentage of α becomes acetylated on Lys-298 under 
the conditions tested, since this value has to be obtained by quantitative mass spec-
trometry methods. However, clues exist to suggest that the majority of α isolated 
from glucose-exposed WT cells is acetylated. These clues come from the fact that 
trypsin, the protease used to obtain the MS-analyzed peptides, cleaves after lysines 
but not after acetyllysines. From glucose-naïve WT cells, we detected the non-
acetylated peptides (291-297) TPNLGK and (299-310) SLTEIKDVLASR, suggesting 
that Lys-297 and Lys-298 were not acetylated. In contrast, from glucose-exposed 
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WT cells, our collaborators detected the related but acetylated peptides (291-298) 
TPNLGK297(+42)K and (298-304) K298(+42)SLTEIK, suggesting that Lys-297 and 
Lys-298 could be acetylated. Strikingly, the inability to detect the non-acetylated 
peptides TPNLGK and SLTEIKDVLASR in glucose-exposed samples suggests that 
much of the α isolated from glucose-exposed WT cells is acetylated on Lys-297 and 
Lys-298.  
 How could acetylation of Lys-298 affect cpxP transcription? Analysis of the 
crystal structure of CRP and αCTD bound to a synthetic DNA fragment containing 
two CRP binding sites flanked by αCTD binding sites suggests that Lys-298 of α 
makes direct interaction with DNA adjacent to the CRP binding site (7). Thus, Lys-
298 likely plays a role in closed complex formation, the first step in transcription 
initiation. So how could acetylation of Lys-298 work? While I cannot definitively an-
swer how acetylation of Lys-298 contributes to cpxP transcription, it is possible that 
non-acetylated αCTD binds to a site that is not conducive to CpxR-dependent activa-
tion. If so, the acetylation of Lys-298 could re-position the αCTD, permitting it to 
make productive contact with CpxR. Alternatively, CpxR and RNAP could form an 
overly stable complex that binds tightly to the cpxP promoter. If so, then acetylation 
of Lys-298 might loosen this interaction, facilitating promoter clearance. Whichever 
mechanism is true, it should be noted that although Lys-298 is required for glucose-
induced cpxP transcription, it may not be sufficient; other acetylated lysines on the 
surface of the other RNAP subunits might also participate. Additionally, Lys-298 is 
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not required for CpxA-dependent activation of cpxP, suggesting a distinct activation 
mechanism.  
 Other questions remain: What are the general rules for activation? How gen-
eral is the effect of Lys-298 acetylation? Does protein acetylation influence tran-
scription from other CpxR-dependent promoters? Does it influence CpxR-
independent promoters? There is evidence that the response to glucose and other 
carbon sources is context-dependent, i.e. some CpxR-dependent promoters respond 
to carbon source exposure and some do not (A. Cosgrove, B. P. Lima and A. J. Wolfe, 
unpublished data). This context-dependence suggests that the mechanism(s) by 
which acetylation influences transcription is not simple, and may involve factors 
such as promoter architecture and nucleoprotein complex composition. 
 
A ROLE FOR ACETYLATED Lys-291 
The acetylation profile of α isolated from the cpxA ackA mutant differed from 
the acetylation profile of α isolated from its WT parent. Thus, it appears that RNAP 
can become acetylated on multiple lysine residues on different subunits and that the 
acetylation pattern of RNAP can differ depending on genetic background and growth 
condition. While one α acetylation was common to both strains, five acetylations 
were specific to the cpxA ackA mutant including Lys-291, which had been shown by 
other to be acetylated (ref), and only one was specific to WT (i.e., Lys-298). The ge-
netic screen conducted here suggests that Lys-291 is definitely involved in weaken-
ing the response to 0.4% glucose by the ackA mutant or to 4.0% glucose by its WT 
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parent. I currently do not possess definitive evidence that acetylation of Lys-291 
causes these behaviors; however, support for such a mechanism is provided by the 
dramatic reduction in glucose-induced cpxP transcription by the K291Q mutation, 
which is predicted to exhibit properties that mimic acetylated Lys-291 (25). While 
the underlying molecular mechanism remains to be determined, it is distinctly pos-
sible that Lys-291 acetylation could affect one of the many interactions made by α 
and, as a result, decrease the stability of the transcription complex. Lys-291 is locat-
ed on the αCTD helix-hairpin-helix motif, which is reported to contribute to both 
nucleic acid binding and protein-protein interaction (117).  To the best of my 
knowledge, no evidence exists that Lys-291 makes direct contact with DNA. In con-
trast, Lys-291 has been reported to make direct contact with activation region 2 of 
the transcription antiterminator NusA (116). Furthermore, Lys-291 is located near 
the 287 determinant, an αCTD surface known to make direct contact with the catab-
olite activator protein (CAP, also known as CRP) [reviewed in (14)]. Although no di-
rect evidence exists for an αCTD-CpxR interaction, our report that the αCTD is re-
quired for glucose-induced cpxP transcription (83) hints that an interaction be-
tween these two proteins might exist, perhaps in manner similar to that reported 
for OmpR, another member of the winged-helix-turn-helix family of response regu-
lators [reviewed in (67)]. 
 Using the well-characterized CRP-αCTD interaction as a guide, we hypothe-
size that Lys-291 might participate in an interaction between CpxR and the αCTD. If 
so, then the acetylation of Lys-291 could affect this interaction and therefore impact 
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transcription. Efforts are underway to identify the mechanism by which Lys-291 
and its acetylation affect cpxP transcription.  
 
MODEL 
 I envision a simple model that accounts for all the observations presented 
here. When a cell grows in buffered TB, the lack of a strong extracytoplasmic stimu-
lus permits CpxA to function as a net phosphatase, removing phosphoryl groups 
from phospho-CpxR. If that cell becomes exposed to a carbon source (e.g. glucose, 
pyruvate, lactate or acetate) whose metabolism results in an increase in intracellu-
lar AcP concentration, then the increased AcP concentration leads to phosphoryla-
tion of certain RRs (including CpxR) and to acetylation of more than 10% of total E. 
coli proteins, including proteins that comprise RNAP. If metabolism of that carbon 
source (e.g. glucose or lactate) also requires an NAD+-dependent enzyme (e.g. 
glyceraldehyde dehydrogenase or lactate dehydrogenase, respectively), then a com-
petition might ensue with the NAD+-dependent deacetylase CobB for the limited 
supply of NAD+. This competition would result in reduced deacetylation of CobB tar-
gets. The result would be a dramatic increase in the acetylation of certain proteins, 
including many that regulate transcription. 
 YfiQ influences the pattern of RNAP acetylation; however, the mechanism 
remains unknown. One possibility could be that a YfiQ-dependent effect on carbon 
flux through central metabolism could influence AcP concentration, and thus lead to 
changes in the acetylation pattern of RNAP. Distinct acetylation sites on RNAP could 
130 
 
 
 
differentially impact its activities, including its ability to bind to promoters and to 
interact with transcription factors. The outcome of RNAP acetylation at the level of 
cpxP transcription seems to be either activation (if Lys-298 is acetylated) or inhibi-
tion (if Lys-291 is acetylated). 
 Several important questions remain unanswered. Does YfiQ directly acety-
late RNAP and does this acetylation affect cpxP transcription. How does AcP affect 
the overall pattern of protein acetylation? Do acetyltransferases exist that can utilize 
AcP as the acetyl donor? Does the in vitro acetylation of RNAP by AcP represent a 
situation that occurs in vivo? CobB impact on overall protein acetylation seems to 
have been modest. Is this a clue that other unidentified protein deacetylases exit in 
E. coli? What is the overall transcriptional impact of RNAP acetylation?  
 In summary, I propose that AcP can function as a phosphoryl donor to CpxR, 
both in vitro and in vivo and an acetyl donor to RNAP at least in vitro and probably in 
vivo. The output of this multiple modification, at the level of the cpxP promoter, 
seems to be modulation of the strength of cpxP transcription. My work suggests that 
acetylation of Lys-298 somehow contributes to promoter activity, whereas acetyla-
tion of Lys-291 dampens this activation. 
 
CONCLUDING REMARKS 
 Great strides have been made to understand the role of protein acetylation in 
eukaryotes. In contrast, our knowledge of protein acetylation in bacteria remains in 
its infancy. Our current knowledge is restricted to three lists of acetylated bacterial 
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proteins, the structures of several bacterial GNATs, some functions of a single 
acetyltransferase (YfiQ/Pat), a single deacetylase (the NAD+-dependent sirtuin 
CobB), and the effects of acetylation on the functions of three acetylated proteins 
that function in central metabolism, chemotaxis [reviewed in (53)] and RNA metab-
olism (80, 81). The data presented here extends that knowledge by (1) implicating 
AcP as a major determinant in controlling protein acetylation, (2) showing that sev-
eral RNAP subunits can become acetylated on multiple lysines, and (3) demonstrat-
ing that the protein acetylation machinery of E. coli affects transcription of at least 
one promoter, potentially by its ability to modify RNAP, the molecular machine that 
performs transcription of all bacterial genes. 
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Table 1 
Strain and plasmid Table 
Strain Relevant Characteristic Source/Reference 
PAD282 
F- araD139 Δ(argF-lac)U169 
rpsL150(Strr) relA1 flhD5301 deoC1 
λΦ(PcpxP'-lacZ) 
(30) 
PAD292 
PAD282 cpxR1::spc (spectinomycin in-
sertion in cpxR with polar effect on 
cpxA) 
(30) 
PAD348 PAD282 cpxA::cam 
DiGuiseppe & Silhavy 
(Princeton University) 
AJW2790 PAD282 ackA::kan (149) 
AJW2791 PAD282 Δ(ackA pta)::cam (149) 
AJW2794 PAD282 cpxA::cam ackA::kan (149) 
AJW3143 PAD282 yfiQ::kan (83) 
AJW3827 PAD292 ackA::kan (84) 
AJW3875 
PAD292 Δ(ackA pta hisJ hisP dhu) 
zej223::Tn10 
(84) 
AJW3167 PAD282 ΔcpxA::kan (84) 
AJW3994 PAD282 ΔackA::frt (83) 
AJW4303 AJW3994 ΔtmcA::kan (84) 
AJW4304 AJW3994 ΔypeA::kan (84) 
AJW4305 AJW3994 ΔyedL::kan (84) 
AJW4306 AJW3994 Δaat::kan (84) 
AJW4307 AJW3994 ΔyhbS::kan (84) 
AJW4308 AJW3994 ΔyafP::kan (84) 
AJW4309 AJW3994 ΔyiiD::kan (84) 
AJW4310 AJW3994 ΔrimJ::kan (84) 
AJW4311 AJW3994 ΔrimL::kan (84) 
AJW4312 AJW3994 ΔyiaC::kan (84) 
AJW4313 AJW3994 ΔyjhQ::kan (84) 
AJW4314 AJW3994 ΔspeG::kan (84) 
AJW4315 AJW3994 ΔargA::kan (84) 
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AJW4316 AJW3994 ΔrimI::kan (84) 
AJW4317 AJW3994 ΔyhhY::kan (84) 
AJW4318 AJW3994 ΔphnO::kan (84) 
AJW4319 AJW3994 ΔyjdJ::kan (84) 
AJW4320 AJW3994 ΔyjaB::kan (84) 
AJW4321 AJW3994 ΔwecD::kan (84) 
AJW4322 AJW3994 ΔyjgM::kan (84) 
AJW4333 AJW3994 ΔyncA::kan (84) 
AJW4867 PAD282 ΔcpxA::kan ΔackA::frt 
P1:JW3882 → AJW3994 
(KmR) 
AJW1939 ackA::kan (73) 
AJW2013 Δ(ackA pta hisJ hisP dhu) zej223::Tn10 (148) 
JW2293 ΔackA::kan (2) 
JW3882 ΔcpxA::kan (2) 
Plasmid Relevant Characteristics  Source/Reference 
pCA24n Control plasmid (CmR) (71) 
pCA24n-cpxR 
Plasmid expressing 6xHis-CpxR under 
the control of an IPTG-inducible pro-
moter (CmR) 
(71) 
pCA24n-
cpxRD51A 
Plasmid expressing 6xHis-CpxRD51A 
under the control of an IPTG-inducible 
promoter (CmR) 
(84) 
pBPL001 
pET-28 derivative expressing 6xHis-
CpxR under the control of an IPTG-
inducible promoter. (KnR) 
(84) 
p770-cpxP 
p770 derivative expressing cpxP pro-
moter (ApR) 
Unpublished 
pCA24n-yfiQ 
Plasmids expressing 6xHis-yfiQ under 
the control of an IPTG-inducible pro-
moter (CmR) 
(71) 
pCA24n-yiiD 
Plasmids expressing 6xHis-yiiD under 
the control of an IPTG-inducible pro-
moter (CmR) 
(71) 
pCA24n-atoB 
Plasmids expressing 6xHis-atoB under 
the control of an IPTG-inducible pro-
moter (CmR) 
(71) 
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pCA24n-
argA 
Plasmids expressing 6xHis-argA under 
the control of an IPTG-inducible pro-
moter (CmR) 
(71) 
pCA24n-elaA 
Plasmids expressing 6xHis-elaA under 
the control of an IPTG-inducible pro-
moter (CmR) 
(71) 
pCA24n-
yjgM 
Plasmids expressing 6xHis-yjgM under 
the control of an IPTG-inducible pro-
moter (CmR) 
(71) 
pCA24n-yjaB 
Plasmids expressing 6xHis-yjaB under 
the control of an IPTG-inducible pro-
moter (CmR) 
(71) 
pCA24n-
yhhY 
Plasmids expressing 6xHis-yhhY under 
the control of an IPTG-inducible pro-
moter (CmR) 
(71) 
pCA24n-rimJ 
Plasmids expressing 6xHis-rimJ under 
the control of an IPTG-inducible pro-
moter (CmR) 
(71) 
pCA24n-yjdJ 
Plasmids expressing 6xHis-yiid under 
the control of an IPTG-inducible pro-
moter (CmR) 
(71) 
pPHB1 
pGEM-T-Easy derivative expressing 
phbCAB+ (Apr) 
(83) 
pPHB2 
pTAC-85 derivative expressing 
phbCAB+ (Apr) 
(83) 
pREII 
Plasmid expressing WT rpoA or alanine 
substitution derivatives (ApR) 
(39) 
pREII-
rpoAK10A 
pREII derivative expressing rpoAK10A (84) 
pREII-
rpoAK25A 
pREII derivative expressing rpoAK25A (84) 
pREII-
rpoAK95A 
pREII derivative expressing rpoAK95A (84) 
pREII-
rpoAK271A 
pREII derivative expressing rpoAK271A (39) 
pREII-
rpoAK291A 
pREII derivative expressing rpoAK291A (39) 
pREII- pREII derivative expressing rpoAK297A (39) 
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rpoAK297A 
pREII-
rpoAK298A 
pREII derivative expressing rpoAK298A (39) 
pREII-
rpoAK304A 
pREII derivative expressing rpoAK304A (39) 
pREII-
rpoAK291R 
pREII derivative expressing rpoAK291R  (84) 
pREII-
rpoAK291Q 
pREII derivative expressing rpoAK291Q (84) 
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Table 2.  
The number of acetylated  and ’ peptides detected from ackA mutant cells 1 
 
Beta (Glucose-exposed) 
Replicate 
1 
Replicate 
2 
Replicate 
3 
Total Spectra 366 382 305 
(R)EAPEGTVk115(+42)DIK(E) 1 0 0 
(R)QLEk279(+42)DDVK(L) 1 1 0 
(K)LSQSGHk331(+42)R(I) 0 0 1 
(R)Sk639(+42)GESSLFSR(D) 0 1 1 
(R)AVAVDSGVTAVAk719(+42)R(G) 1 0 0 
(R)DTk844(+42)LGPEEITADIPNVGEAALSK(L) 1 0 0 
(K)VTPk890(+42)GETQLTPEEK(L) 1 1 1 
(R)AIFGEk909(+42)ASDVK(D) 1 1 1 
(K)ASDVk914(+42)DSSLR(V) 1 1 1 
(R)ALEIEEMQLk954(+42)QAK(K) 1 1 0 
(R)AVLVAGGVEAEk988(+42)LDK(L) 2 1 1 
(K)LDk991(+42)LPR(D) 1 0 0 
(R)k1035(+42)ITQGDDLAPGVLK(I) 0 1 1 
(R)IQPGDk1065(+42)MAGR(H) 1 0 0 
(R)HGNk1073GVISK(I) 0 1 1 
(K)INAmLk1133(+42)QQQEVAK(L) 1 2 2 
(K)QQQEVAKk140(+42)LR(E) 1 1 1 
(R)k1178(+42)GMPIATPVFDGAK(E) 1 2 2 
(K)ELLk1200LGDLPTSGQIR(L) 0 1 0 
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Beta' (Glucose-exposed) 
Replicate 
1 
Replicate 
2 
Total Spectra 314 248 
(K)AQTk13(+42)TEEFDAIK(I) 1 1 
(R)GLATTIk395(+42)AAK(K) 1 1 
(R)ITEYEk557(+42)DANGELVAK(T) 1 0 
(K)TSLk570(+42)DTTVGR(A) 1 1 
(R)AAAESSIQVk953(+42)NK(G) 0 1 
(K)GSIk959(+42)LSNVK(S) 1 1 
 
 
 
1Red, acetylated peptides detected in at least two biological replicates; 
Black, acetylated peptides detected in one biological replicate; m, oxidized 
methionine, M, methionine; k, acetylated lysine; K, lysine. 
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Table 3.  
ACETYLATED  PEPTIDES FROM ackA MUTANT CELLS1. 
 
 
 
1 Green, unacetylated peptides; Red, acetylated peptides  
2 m, oxidized methionine; M, methionine; k, acetylated lysine; K, lysine  
3 Supplemental Table in which the raw data is presented
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TABLE 4 
 
 
Table 4. Immunoprecipitated β and β′ proteins were separated by SDS-PAGE and β 
and β′ bands were digested with trypsin, as described (20). The resulting peptides 
were analyzed in a LTQ OrbitrapXL mass spectrometer, as described in the experi-
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mental procedures section and analyzed using the Scaffold software. The table 
shows the Xcorr, DCn scores, charges, both the observed precursor m/z and actual 
peptide mass, and the mass deviation (delta ppm) of all 15 K-acetylated peptides 
detected for b and 11 Lys-acetylated peptides detected for β′ in the glucose-exposed 
samples.
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